Stat3	B-protein
recruitment	O
by	O
two	O
distinct	O
ligand-induced	B-protein
,	I-protein
tyrosine-phosphorylated	I-protein
docking	I-protein
sites	I-protein
in	O
the	O
interleukin-10	B-protein
receptor	I-protein
intracellular	I-protein
domain	I-protein
.	O

Recent	O
work	O
has	O
shown	O
that	O
IL-10	B-protein
induces	O
activation	O
of	O
the	O
JAK	B-protein
-STAT	B-protein
signaling	O
pathway	O
.	O

To	O
define	O
the	O
mechanism	O
underlying	O
signal	B-protein
transducer	I-protein
and	I-protein
activator	I-protein
of	I-protein
transcription	I-protein
(	I-protein
STAT	I-protein
)	I-protein
protein	I-protein
recruitment	O
to	O
the	O
interleukin	B-protein
10	I-protein
(	I-protein
IL-10	I-protein
)	I-protein
receptor	I-protein
,	O
the	O
STAT	B-protein
proteins	I-protein
activated	O
by	O
IL-10	B-protein
in	O
different	O
cell	O
populations	O
were	O
first	O
defined	O
using	O
electrophoretic	O
mobility	O
shift	O
assays	O
.	O

In	O
all	O
cells	O
tested	O
,	O
IL-10	B-protein
activated	O
Stat1	B-protein
and	O
Stat3	B-protein
and	O
induced	O
the	O
formation	O
of	O
three	O
distinct	O
DNA	B-protein
binding	I-protein
complexes	I-protein
that	O
contained	O
different	O
combinations	O
of	O
these	O
two	O
transcription	B-protein
factors	I-protein
.	O

IL-10	B-protein
also	O
activated	O
Stat5	B-protein
in	O
Ba/F3	B-cell_line
cells	I-cell_line
that	O
stably	O
expressed	O
the	O
murine	O
IL-10	B-protein
receptor	I-protein
.	O

Using	O
a	O
structure-function	O
mutagenesis	O
approach	O
,	O
two	O
tyrosine	O
residues	O
(	O
Tyr427	O
and	O
Tyr477	O
)	O
in	O
the	O
intracellular	B-protein
domain	I-protein
of	O
the	O
murine	O
IL-10	B-protein
receptor	O
were	O
found	O
to	O
be	O
redundantly	O
required	O
for	O
receptor	O
function	O
and	O
for	O
activation	O
of	O
Stat3	B-protein
but	O
not	O
for	O
Stat1	B-protein
or	O
Stat5	B-protein
.	O

Twelve	O
amino	O
acid	O
peptides	O
encompassing	O
either	O
of	O
these	O
two	O
tyrosine	O
residues	O
in	O
phosphorylated	B-protein
form	I-protein
coprecipitated	O
Stat3	B-protein
but	O
not	O
Stat1	B-protein
and	O
blocked	O
IL-10	B-protein
-induced	O
Stat3	B-protein
phosphorylation	O
in	O
a	O
cell-free	O
system	O
.	O

In	O
contrast	O
,	O
tyrosine-phosphorylated	O
peptides	O
containing	O
Tyr374	O
or	O
Tyr396	O
did	O
not	O
interact	O
with	O
Stat3	B-protein
or	O
block	O
Stat3	B-protein
activation	O
.	O

These	O
data	O
demonstrate	O
that	O
Stat3	B-protein
but	O
not	O
Stat1	B-protein
or	O
Stat5	B-protein
is	O
directly	O
recruited	O
to	O
the	O
ligand-activated	B-protein
IL-10	I-protein
receptor	I-protein
by	O
binding	O
to	O
specific	O
but	O
redundant	O
receptor	B-protein
intracellular	I-protein
domain	I-protein
sequences	I-protein
containing	O
phosphotyrosine	O
.	O

This	O
study	O
thus	O
supports	O
the	O
concept	O
that	O
utilization	O
of	O
distinct	O
STAT	B-protein
proteins	I-protein
by	O
different	O
cytokine	B-protein
receptors	I-protein
is	O
dependent	O
on	O
the	O
expression	O
of	O
particular	O
ligand-activatable	O
,	O
tyrosine-containing	B-protein
STAT	I-protein
docking	I-protein
sites	I-protein
in	O
receptor	B-protein
intracellular	I-protein
domains	I-protein
.	O

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

271	NULL
,	NULL
No	NULL
.	NULL

44	NULL
,	NULL
Issue	NULL
of	NULL
November	NULL
1	NULL
,	NULL
pp	NULL
.	NULL

27954-27961	NULL
,	NULL
1996	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Stat3	NULL
Recruitment	NULL
by	NULL
Two	NULL
Distinct	NULL
Ligand-induced	NULL
,	NULL
Tyrosine-phosphorylated	NULL
Docking	NULL
Sites	NULL
in	NULL
the	NULL
Interleukin-10	NULL
Receptor	NULL
Intracellular	NULL
Domain*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
August	NULL
6	NULL
,	NULL
1996	NULL
)	NULL
Renate	NULL
M.	NULL
Weber-Nordt	NULL
#	NULL
§1	NULL
,	NULL
Joan	NULL
K.	NULL
Riley	NULL
$	NULL
§	NULL
,	NULL
Andrew	NULL
C.	NULL
Greenlund	NULL
?	NULL

#	NULL
,	NULL
Kevin	NULL
W	NULL
.	NULL

Moore	NULL
!	NULL

,	NULL
James	NULL
E.	NULL
Darnell**	NULL
,	NULL
and	NULL
Robert	NULL
D.	NULL
Schreiber	NULL
?	NULL

#	NULL
#	NULL
From	NULL
the	NULL
{	NULL
Center	NULL
for	NULL
Immunology	NULL
,	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Missouri	NULL
63110	NULL
,	NULL
Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
DNAX	NULL
Research	NULL
Institute	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
California	NULL
94304	NULL
,	NULL
and	NULL
**Laboratory	NULL
of	NULL
Molecular	NULL
Cell	NULL
Biology	NULL
,	NULL
Rockefeller	NULL
University	NULL
,	NULL
New	NULL
York	NULL
,	NULL
New	NULL
York	NULL
10021	NULL
Recent	NULL
work	NULL
has	NULL
shown	NULL
that	NULL
IL-10	NULL
induces	NULL
activation	NULL
of	NULL
the	NULL
JAK-STAT	NULL
signaling	NULL
pathway	NULL
.	NULL

To	NULL
define	NULL
the	NULL
mechanism	NULL
underlying	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
(	NULL
STAT	NULL
)	NULL
protein	NULL
recruitment	NULL
to	NULL
the	NULL
interleukin	NULL
10	NULL
(	NULL
IL-10	NULL
)	NULL
receptor	NULL
,	NULL
the	NULL
STAT	NULL
proteins	NULL
activated	NULL
by	NULL
IL-10	NULL
in	NULL
different	NULL
cell	NULL
populations	NULL
were	NULL
first	NULL
defined	NULL
using	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

In	NULL
all	NULL
cells	NULL
tested	NULL
,	NULL
IL-10	NULL
activated	NULL
Statl	NULL
and	NULL
Stat3	NULL
and	NULL
induced	NULL
the	NULL
formation	NULL
of	NULL
three	NULL
distinct	NULL
DNA	NULL
binding	NULL
complexes	NULL
that	NULL
contained	NULL
different	NULL
combinations	NULL
of	NULL
these	NULL
two	NULL
transcription	NULL
factors	NULL
.	NULL

IL-10	NULL
also	NULL
activated	NULL
Stat5	NULL
in	NULL
Ba/F3	NULL
cells	NULL
that	NULL
stably	NULL
expressed	NULL
the	NULL
murine	NULL
IL-10	NULL
receptor	NULL
.	NULL

Using	NULL
a	NULL
structure-function	NULL
mutagenesis	NULL
approach	NULL
,	NULL
two	NULL
tyrosine	NULL
residues	NULL
(	NULL
Tyr*	NULL
``	NULL
and	NULL
Tyr*	NULL
'	NULL
``	NULL
)	NULL
in	NULL
the	NULL
intracellular	NULL
domain	NULL
of	NULL
the	NULL
murine	NULL
IL-10	NULL
receptor	NULL
were	NULL
found	NULL
to	NULL
be	NULL
redundantly	NULL
required	NULL
for	NULL
receptor	NULL
function	NULL
and	NULL
for	NULL
activation	NULL
of	NULL
Stat3	NULL
but	NULL
not	NULL
for	NULL
Stat1	NULL
or	NULL
Stat5	NULL
.	NULL

Twelve	NULL
amino	NULL
acid	NULL
peptides	NULL
encompassing	NULL
either	NULL
of	NULL
these	NULL
two	NULL
tyrosine	NULL
residues	NULL
in	NULL
phosphorylated	NULL
form	NULL
coprecipitated	NULL
Stat3	NULL
but	NULL
not	NULL
Stat1l	NULL
and	NULL
blocked	NULL
IL-10-induced	NULL
Stat3	NULL
phosphorylation	NULL
in	NULL
a	NULL
cell-free	NULL
system	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
tyrosine-phosphorylated	NULL
peptides	NULL
containing	NULL
or	NULL
Tyr®	NULL
``	NULL
®	NULL
did	NULL
not	NULL
interact	NULL
with	NULL
Stat3	NULL
or	NULL
block	NULL
Stat3	NULL
activation	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
Stat3	NULL
but	NULL
not	NULL
Statl	NULL
or	NULL
Stat5	NULL
is	NULL
directly	NULL
recruited	NULL
to	NULL
the	NULL
ligand-activated	NULL
IL-10	NULL
receptor	NULL
by	NULL
binding	NULL
to	NULL
specific	NULL
but	NULL
redundant	NULL
receptor	NULL
intracellular	NULL
domain	NULL
sequences	NULL
containing	NULL
phosphotyrosine	NULL
.	NULL

This	NULL
study	NULL
thus	NULL
supports	NULL
the	NULL
concept	NULL
that	NULL
utilization	NULL
of	NULL
distinct	NULL
STAT	NULL
proteins	NULL
by	NULL
different	NULL
cytokine	NULL
receptors	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
particular	NULL
ligand-activat-able	NULL
,	NULL
tyrosine-containing	NULL
STAT	NULL
docking	NULL
sites	NULL
in	NULL
receptor	NULL
intracellular	NULL
domains	NULL
.	NULL

Interleukin-10	NULL
(	NULL
IL-10	NULL
)	NULL
'	NULL
is	NULL
a	NULL
cytokine	NULL
produced	NULL
by	NULL
ThO	NULL
and	NULL
Th2	NULL
CD4*	NULL
T	NULL
cells	NULL
,	NULL
CD5¢*	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
macrophages	NULL
(	NULL
1-5	NULL
)	NULL
that	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
USPHS	NULL
Grant	NULL
CA48059	NULL
and	NULL
a	NULL
grant	NULL
from	NULL
Monsanto	NULL
Corporation	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
17834	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

§	NULL
These	NULL
authors	NULL
contributed	NULL
equally	NULL
to	NULL
the	NULL
study	NULL
.	NULL

4	NULL
Recipient	NULL
of	NULL
the	NULL
BASF-Forschungsstipedium	NULL
of	NULL
the	NULL
Studienstiftung	NULL
des	NULL
deutschen	NULL
Volkes	NULL
.	NULL

Present	NULL
address	NULL
:	NULL
Albert-Ludwigs-Universitat	NULL
,	NULL
Freiburg	NULL
,	NULL
Germany	NULL
.	NULL

7+	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Pathology	NULL
,	NULL
Mailstop	NULL
Box	NULL
8118	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
660	NULL
South	NULL
Euclid	NULL
Ave.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
63110	NULL
Tel	NULL
.	NULL

:	NULL
814-862-8747	NULL
;	NULL
Fax	NULL
:	NULL
814-362-8888	NULL
;	NULL
E-mail	NULL
:	NULL
schreiber	NULL
@	NULL
immunology.wustl.edu	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
IFN	NULL
,	NULL
interferon	NULL
;	NULL
JAK	NULL
,	NULL
Janus	NULL
kinase	NULL
;	NULL
STATs	NULL
,	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcrip-	NULL
tion	NULL
;	NULL
SH2	NULL
,	NULL
Sre	NULL
homology	NULL
2	NULL
;	NULL
mAb	NULL
,	NULL
monoclonal	NULL
antibody	NULL
;	NULL
PAGE	NULL
,	NULL
poly-	NULL
inhibits	NULL
inflammatory	NULL
and	NULL
cell-mediated	NULL
immune	NULL
responses	NULL
while	NULL
enhancing	NULL
humoral	NULL
immunity	NULL
(	NULL
6-9	NULL
)	NULL
.	NULL

IL-10	NULL
exerts	NULL
its	NULL
pleiotropic	NULL
effects	NULL
following	NULL
interaction	NULL
with	NULL
a	NULL
specific	NULL
IL-10	NULL
receptor	NULL
that	NULL
is	NULL
expressed	NULL
in	NULL
low	NULL
numbers	NULL
on	NULL
IL-10-responsive	NULL
cells	NULL
(	NULL
1	NULL
,	NULL
10	NULL
)	NULL
.	NULL

IL-10	NULL
binds	NULL
to	NULL
its	NULL
receptor	NULL
in	NULL
a	NULL
homogeneous	NULL
manner	NULL
with	NULL
high	NULL
affinity	NULL
(	NULL
K	NULL
,	NULL
=	NULL
9	NULL
x	NULL
10°	NULL
m~*	NULL
)	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

The	NULL
cDNA	NULL
encoding	NULL
the	NULL
ligand-binding	NULL
polypeptide	NULL
of	NULL
the	NULL
IL-10	NULL
receptor	NULL
was	NULL
recently	NULL
cloned	NULL
,	NULL
and	NULL
the	NULL
receptor	NULL
polypeptide	NULL
was	NULL
characterized	NULL
as	NULL
a	NULL
110-kDa	NULL
glycoprotein	NULL
(	NULL
1	NULL
,	NULL
10	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
sequence	NULL
homology	NULL
,	NULL
this	NULL
protein	NULL
has	NULL
been	NULL
characterized	NULL
as	NULL
a	NULL
member	NULL
of	NULL
the	NULL
type	NULL
II	NULL
cytokine	NULL
receptor	NULL
family	NULL
that	NULL
also	NULL
contains	NULL
the	NULL
IFNa	NULL
and	NULL
IFNy	NULL
receptor	NULL
polypeptides	NULL
(	NULL
13	NULL
)	NULL
.	NULL

This	NULL
single	NULL
chain	NULL
does	NULL
not	NULL
reconstitute	NULL
a	NULL
functionally	NULL
active	NULL
IL-10	NULL
receptor	NULL
when	NULL
expressed	NULL
in	NULL
fibroblasts	NULL
,	NULL
indicating	NULL
that	NULL
at	NULL
least	NULL
one	NULL
additional	NULL
polypeptide	NULL
is	NULL
required	NULL
.	NULL

However	NULL
,	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
accessory	NULL
molecule	NULL
(	NULL
s	NULL
)	NULL
has	NULL
not	NULL
been	NULL
established	NULL
.	NULL

Receptor	NULL
proteins	NULL
belonging	NULL
to	NULL
the	NULL
type	NULL
I	NULL
and	NULL
type	NULL
II	NULL
cytokine	NULL
receptor	NULL
families	NULL
are	NULL
now	NULL
known	NULL
to	NULL
utilize	NULL
the	NULL
JAK-STAT	NULL
family	NULL
of	NULL
proteins	NULL
for	NULL
signal	NULL
transduction	NULL
(	NULL
14-22	NULL
)	NULL
.	NULL

Currently	NULL
,	NULL
this	NULL
family	NULL
consists	NULL
of	NULL
four	NULL
Janus	NULL
family	NULL
tyrosine	NULL
kinases	NULL
(	NULL
JAK-1	NULL
,	NULL
JAK-2	NULL
,	NULL
JAK-3	NULL
,	NULL
and	NULL
TYK-2	NULL
)	NULL
and	NULL
seven	NULL
latent	NULL
cytosolic	NULL
transcription	NULL
factors	NULL
(	NULL
Stat1l-Stat6	NULL
)	NULL
.	NULL

Recent	NULL
work	NULL
has	NULL
indicated	NULL
that	NULL
each	NULL
cytokine	NULL
receptor	NULL
uses	NULL
a	NULL
distinct	NULL
but	NULL
often	NULL
overlapping	NULL
combination	NULL
of	NULL
JAKs	NULL
and	NULL
STAT	NULL
's	NULL
to	NULL
effect	NULL
development	NULL
of	NULL
cytokine-specific	NULL
cellular	NULL
responses	NULL
.	NULL

Thus	NULL
,	NULL
at	NULL
least	NULL
some	NULL
of	NULL
the	NULL
specificity	NULL
of	NULL
this	NULL
signal	NULL
transduction	NULL
pathway	NULL
appears	NULL
to	NULL
be	NULL
determined	NULL
by	NULL
the	NULL
recruitment	NULL
of	NULL
particular	NULL
STAT	NULL
proteins	NULL
to	NULL
the	NULL
activated	NULL
receptor	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
obtained	NULL
insights	NULL
into	NULL
the	NULL
mechanism	NULL
underlying	NULL
STAT	NULL
recruitment	NULL
by	NULL
cytokine	NULL
receptors	NULL
though	NULL
experiments	NULL
that	NULL
focused	NULL
on	NULL
defining	NULL
the	NULL
structure	NULL
and	NULL
function	NULL
of	NULL
the	NULL
IFNy	NULL
receptor	NULL
in	NULL
signaling	NULL
the	NULL
induction	NULL
of	NULL
cellular	NULL
responses	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

That	NULL
work	NULL
revealed	NULL
that	NULL
IFNy-IFNy	NULL
receptor	NULL
interaction	NULL
leads	NULL
to	NULL
the	NULL
rapid	NULL
phosphorylation	NULL
of	NULL
a	NULL
particular	NULL
tyrosine	NULL
contained	NULL
within	NULL
the	NULL
pentameric	NULL
sequence	NULL
YDKPH	NULL
in	NULL
the	NULL
intracellular	NULL
domain	NULL
of	NULL
the	NULL
human	NULL
and	NULL
murine	NULL
IFNy	NULL
receptor	NULL
a	NULL
chains	NULL
(	NULL
residues	NULL
440-444	NULL
and	NULL
420-424	NULL
in	NULL
the	NULL
human	NULL
and	NULL
murine	NULL
proteins	NULL
,	NULL
respectively	NULL
)	NULL
(	NULL
24	NULL
)	NULL
.	NULL

A	NULL
peptide	NULL
containing	NULL
the	NULL
phosphorylated	NULL
YDKPH	NULL
sequence	NULL
bound	NULL
to	NULL
Statl	NULL
and	NULL
prevented	NULL
ligand-induced	NULL
Statl	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
expression	NULL
of	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

This	NULL
sequence	NULL
thus	NULL
appears	NULL
to	NULL
act	NULL
as	NULL
the	NULL
IFNy	NULL
receptor	NULL
docking	NULL
site	NULL
for	NULL
Statl	NULL
but	NULL
not	NULL
for	NULL
any	NULL
other	NULL
STAT	NULL
family	NULL
member	NULL
.	NULL

Using	NULL
purified	NULL
recombinant	NULL
proteins	NULL
,	NULL
we	NULL
found	NULL
that	NULL
Stat1	NULL
binds	NULL
directly	NULL
to	NULL
the	NULL
phosphorylated	NULL
YDKPH	NULL
sequence	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
latter	NULL
result	NULL
thus	NULL
eliminates	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
interaction	NULL
is	NULL
mediated	NULL
through	NULL
an	NULL
acrylamide	NULL
gel	NULL
electrophoresis	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
PEC	NULL
,	NULL
peritoneal	NULL
exudate	NULL
macrophage	NULL
cell	NULL
.	NULL

27954	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Stat3	NULL
Recruitment	NULL
by	NULL
the	NULL
IL-10	NULL
Receptor	NULL
adapter	NULL
protein	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
observations	NULL
suggest	NULL
a	NULL
mechanism	NULL
whereby	NULL
STAT	NULL
protein	NULL
recruitment	NULL
by	NULL
distinct	NULL
cytokine	NULL
receptors	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
SH2	NULL
domain	NULL
in	NULL
the	NULL
STAT	NULL
protein	NULL
for	NULL
a	NULL
particular	NULL
phosphotyrosine-containing	NULL
sequence	NULL
motif	NULL
within	NULL
the	NULL
intracellular	NULL
domain	NULL
of	NULL
the	NULL
cytokine	NULL
receptor	NULL
.	NULL

This	NULL
concept	NULL
has	NULL
been	NULL
strongly	NULL
supported	NULL
by	NULL
subsequent	NULL
work	NULL
showing	NULL
that	NULL
the	NULL
specific	NULL
array	NULL
of	NULL
STAT	NULL
proteins	NULL
recruited	NULL
by	NULL
ligated	NULL
cytokine	NULL
receptors	NULL
can	NULL
be	NULL
altered	NULL
either	NULL
by	NULL
adding	NULL
sequences	NULL
from	NULL
other	NULL
receptors	NULL
that	NULL
recruit	NULL
different	NULL
STAT	NULL
proteins	NULL
(	NULL
26	NULL
)	NULL
or	NULL
by	NULL
exchanging	NULL
the	NULL
SH2	NULL
domains	NULL
of	NULL
one	NULL
STAT	NULL
for	NULL
another	NULL
(	NULL
27	NULL
)	NULL
.	NULL

To	NULL
explore	NULL
the	NULL
generality	NULL
of	NULL
this	NULL
mechanism	NULL
,	NULL
we	NULL
have	NULL
studied	NULL
signaling	NULL
through	NULL
the	NULL
ligated	NULL
IL-10	NULL
receptor	NULL
.	NULL

This	NULL
model	NULL
was	NULL
selected	NULL
because	NULL
:	NULL
(	NULL
a	NULL
)	NULL
IL-10	NULL
receptors	NULL
are	NULL
known	NULL
to	NULL
belong	NULL
to	NULL
the	NULL
same	NULL
cytokine	NULL
receptor	NULL
family	NULL
as	NULL
the	NULL
IFN	NULL
receptors	NULL
;	NULL
(	NULL
6	NULL
)	NULL
ligation	NULL
of	NULL
the	NULL
IL-10	NULL
receptor	NULL
results	NULL
in	NULL
activation	NULL
of	NULL
the	NULL
JAK-STAT	NULL
signaling	NULL
pathway	NULL
(	NULL
28-31	NULL
)	NULL
;	NULL
and	NULL
(	NULL
c	NULL
)	NULL
IL-10	NULL
induces	NULL
pleiotropic	NULL
biologic	NULL
responses	NULL
that	NULL
are	NULL
distinct	NULL
from	NULL
those	NULL
induced	NULL
by	NULL
IFNy	NULL
(	NULL
2	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
IL-10	NULL
activates	NULL
Statl	NULL
,	NULL
Stat3	NULL
,	NULL
and	NULL
in	NULL
certain	NULL
cells	NULL
,	NULL
Stat5	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
three	NULL
or	NULL
(	NULL
in	NULL
certain	NULL
cells	NULL
)	NULL
four	NULL
distinct	NULL
DNA	NULL
binding	NULL
complexes	NULL
.	NULL

We	NULL
show	NULL
that	NULL
a	NULL
pair	NULL
of	NULL
tyrosine	NULL
residues	NULL
residing	NULL
at	NULL
positions	NULL
427	NULL
and	NULL
477	NULL
within	NULL
the	NULL
intracellular	NULL
domain	NULL
of	NULL
the	NULL
murine	NULL
IL-10	NULL
receptor	NULL
are	NULL
obligatorily	NULL
required	NULL
for	NULL
Stat3	NULL
recruitment	NULL
but	NULL
not	NULL
for	NULL
Statl	NULL
or	NULL
Stato	NULL
recruitment	NULL
and	NULL
for	NULL
induction	NULL
of	NULL
an	NULL
IL-10-dependent	NULL
biologic	NULL
response	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
define	NULL
the	NULL
Stat3	NULL
binding	NULL
sites	NULL
on	NULL
the	NULL
IL-10	NULL
receptor	NULL
and	NULL
demonstrate	NULL
that	NULL
phosphopeptides	NULL
containing	NULL
these	NULL
docking	NULL
sites	NULL
bind	NULL
selectively	NULL
to	NULL
Stat3	NULL
but	NULL
not	NULL
Statl	NULL
and	NULL
inhibit	NULL
ligand-dependent	NULL
Stat3	NULL
activation	NULL
in	NULL
a	NULL
cell-free	NULL
system	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
results	NULL
demonstrate	NULL
the	NULL
specific	NULL
recruitment	NULL
of	NULL
Stat3	NULL
by	NULL
the	NULL
IL-10	NULL
receptor	NULL
,	NULL
document	NULL
the	NULL
functional	NULL
relevance	NULL
of	NULL
this	NULL
recruitment	NULL
,	NULL
and	NULL
demonstrate	NULL
a	NULL
novel	NULL
process	NULL
whereby	NULL
different	NULL
STAT	NULL
proteins	NULL
are	NULL
recruited	NULL
by	NULL
different	NULL
docking	NULL
sites	NULL
on	NULL
the	NULL
same	NULL
receptor	NULL
.	NULL

The	NULL
latter	NULL
results	NULL
thus	NULL
form	NULL
the	NULL
basis	NULL
for	NULL
a	NULL
novel	NULL
mechanism	NULL
by	NULL
which	NULL
a	NULL
single	NULL
cytokine	NULL
receptor	NULL
can	NULL
effect	NULL
multiple	NULL
STAT	NULL
protein	NULL
recruitment	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Cells	NULL
Primary	NULL
murine	NULL
splenocytes	NULL
and	NULL
resident	NULL
peritoneal	NULL
macrophages	NULL
were	NULL
obtained	NULL
from	NULL
naive	NULL
BALB/c	NULL
mice	NULL
(	NULL
The	NULL
Jackson	NULL
Laboratory	NULL
,	NULL
Bar	NULL
Harbor	NULL
,	NULL
ME	NULL
)	NULL
.	NULL

Macrophages	NULL
were	NULL
allowed	NULL
to	NULL
adhere	NULL
to	NULL
six-well	NULL
cell	NULL
culture	NULL
plates	NULL
in	NULL
4	NULL
ml	NULL
of	NULL
complete	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
1	NULL
mM	NULL
sodium	NULL
pyruvate	NULL
,	NULL
2	NULL
%	NULL
L-glutamine	NULL
,	NULL
50	NULL
units/ml	NULL
penicillin	NULL
,	NULL
and	NULL
50	NULL
ug/ml	NULL
streptomycin	NULL
.	NULL

Ba/F3	NULL
is	NULL
an	NULL
IL-3-dependent	NULL
murine	NULL
pro-B	NULL
cell	NULL
line	NULL
that	NULL
lacks	NULL
IL-10	NULL
receptors	NULL
and	NULL
was	NULL
propagated	NULL
as	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Ba/F3	NULL
derivatives	NULL
expressing	NULL
wild-type	NULL
(	NULL
BaMR	NULL
)	NULL
or	NULL
mutant	NULL
murine	NULL
IL-10	NULL
receptors	NULL
were	NULL
prepared	NULL
by	NULL
stably	NULL
transfecting	NULL
cells	NULL
with	NULL
expression	NULL
plasmids	NULL
encoding	NULL
the	NULL
appropriate	NULL
receptor	NULL
form	NULL
followed	NULL
by	NULL
selection	NULL
with	NULL
G418	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Gaith-ersburg	NULL
,	NULL
MD	NULL
)	NULL
as	NULL
described	NULL
(	NULL
10	NULL
,	NULL
31	NULL
)	NULL
.	NULL

Surviving	NULL
cell	NULL
populations	NULL
were	NULL
cloned	NULL
,	NULL
and	NULL
single	NULL
cell	NULL
clones	NULL
were	NULL
expanded	NULL
and	NULL
maintained	NULL
by	NULL
culture	NULL
in	NULL
IL-8	NULL
.	NULL

IL-10	NULL
receptor	NULL
expression	NULL
in	NULL
each	NULL
cell	NULL
population	NULL
was	NULL
determined	NULL
by	NULL
Scatchard	NULL
analysis	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
murine	NULL
RAW264.7	NULL
macrophage	NULL
cell	NULL
line	NULL
was	NULL
obtained	NULL
from	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
and	NULL
cultured	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
1	NULL
mM	NULL
sodium	NULL
pyruvate	NULL
,	NULL
2	NULL
%	NULL
L-glutamine	NULL
,	NULL
50	NULL
units/ml	NULL
penicillin	NULL
,	NULL
and	NULL
50	NULL
ug/ml	NULL
streptomycin	NULL
as	NULL
described	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Reagents	NULL
Purified	NULL
recombinant	NULL
murine	NULL
IL-10	NULL
(	NULL
specific	NULL
activity	NULL
,	NULL
1.5	NULL
X	NULL
10	NULL
``	NULL
units/	NULL
mg	NULL
)	NULL
was	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Recombinant	NULL
murine	NULL
IFNy	NULL
(	NULL
specific	NULL
activity	NULL
,	NULL
4.7	NULL
X	NULL
10°	NULL
IU/mg	NULL
)	NULL
was	NULL
generously	NULL
provided	NULL
by	NULL
Genentech	NULL
(	NULL
South	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Protein	NULL
G-Sepharose	NULL
was	NULL
purchased	NULL
from	NULL
Pharmacia	NULL
Biotech	NULL
Inc	NULL
.	NULL

Protein	NULL
A-Sepharose	NULL
and	NULL
streptavidin-Sepharose	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
or	NULL
Pierce	NULL
.	NULL

Horseradish	NULL
peroxidase-conjugated	NULL
goat	NULL
antisera	NULL
specific	NULL
for	NULL
rabbit	NULL
IgG	NULL
was	NULL
purchased	NULL
from	NULL
U.	NULL
S.	NULL
Biochemical	NULL
Corp	NULL
.	NULL

The	NULL
4G10	NULL
phosphotyrosine-specific	NULL
mAb	NULL
(	NULL
murine	NULL
IgG2b	NULL
)	NULL
was	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
Brian	NULL
Drucker	NULL
(	NULL
Divi-sion	NULL
of	NULL
Hematology	NULL
,	NULL
Oregon	NULL
Health	NULL
Sciences	NULL
University	NULL
,	NULL
Portland	NULL
,	NULL
OR	NULL
)	NULL
.	NULL

27955	NULL
Horseradish	NULL
peroxidase-conjugated	NULL
antiphosphotyrosine	NULL
mAb	NULL
RC-20	NULL
,	NULL
and	NULL
anti-Stat3	NULL
and	NULL
Stat5	NULL
mAbs	NULL
were	NULL
purchased	NULL
from	NULL
Transduction	NULL
Laboratories	NULL
(	NULL
Lexington	NULL
,	NULL
KY	NULL
)	NULL
.	NULL

Stat5	NULL
rabbit	NULL
polyclonal	NULL
IgG	NULL
was	NULL
obtained	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Different	NULL
polyclonal	NULL
antisera	NULL
specific	NULL
for	NULL
the	NULL
carboxyl-terminal	NULL
regions	NULL
of	NULL
Stat1	NULL
,	NULL
Stat2	NULL
,	NULL
Stat8	NULL
,	NULL
Stat4	NULL
,	NULL
or	NULL
Stat5	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Statl	NULL
mAbs	NULL
ATO-2F5	NULL
and	NULL
ATO-1D6	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Peptides	NULL
The	NULL
following	NULL
peptides	NULL
,	NULL
based	NULL
on	NULL
the	NULL
murine	NULL
IL-10	NULL
receptor	NULL
,	NULL
were	NULL
used	NULL
in	NULL
these	NULL
studies	NULL
:	NULL
370-381	NULL
,	NULL
QQLGYTHqQDQDD	NULL
;	NULL
392-403	NULL
,	NULL
GQPK-YTQDASAL	NULL
;	NULL
423-434	NULL
,	NULL
TFQGYQKQTRWK	NULL
;	NULL
and	NULL
473-484	NULL
,	NULL
LAAGYL-KQESQG	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
following	NULL
human	NULL
IFNy	NULL
receptor	NULL
a	NULL
chain-derived	NULL
peptide	NULL
was	NULL
used	NULL
:	NULL
486-447	NULL
,	NULL
TSFGYDKPHVLV	NULL
.	NULL

Peptides	NULL
were	NULL
synthesized	NULL
on	NULL
an	NULL
Applied	NULL
Biosystems	NULL
model	NULL
482A	NULL
peptide	NULL
synthesizer	NULL
(	NULL
Foster	NULL
City	NULL
,	NULL
CA	NULL
)	NULL
with	NULL
or	NULL
without	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
amino-terminal	NULL
biotin	NULL
group	NULL
using	NULL
the	NULL
biotin-amidocaproate	NULL
N-hydoxysuccinimide	NULL
ester	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
as	NULL
outlined	NULL
in	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Phosphotyrosine-containing	NULL
biotinylated	NULL
and	NULL
nonbiotinylated	NULL
peptides	NULL
were	NULL
synthesized	NULL
using	NULL
FMOC	NULL
(	NULL
N-	NULL
(	NULL
Q-fluorenyl	NULL
)	NULL
methoxycarbonyl	NULL
)	NULL
-phosphoryl-ated	NULL
tyrosine	NULL
obtained	NULL
from	NULL
Advanced	NULL
Chemtech	NULL
(	NULL
Louisville	NULL
,	NULL
KY	NULL
)	NULL
.	NULL

Peptides	NULL
were	NULL
released	NULL
from	NULL
the	NULL
resin	NULL
and	NULL
deprotected	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Peptides	NULL
were	NULL
concentrated	NULL
by	NULL
lyophiliza-tion	NULL
and	NULL
purified	NULL
by	NULL
reversed-phase	NULL
high-performance	NULL
liquid	NULL
chroma-tography	NULL
using	NULL
a	NULL
Vydac	NULL
C	NULL
;	NULL
&	NULL
,	NULL
column	NULL
(	NULL
Hesperia	NULL
,	NULL
CA	NULL
)	NULL
as	NULL
described	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
composition	NULL
of	NULL
the	NULL
peptides	NULL
was	NULL
confirmed	NULL
by	NULL
electrospray	NULL
mass	NULL
spectrometry	NULL
.	NULL

A	NULL
single	NULL
moiety	NULL
was	NULL
detected	NULL
displaying	NULL
the	NULL
appropriate	NULL
molecular	NULL
mass	NULL
for	NULL
each	NULL
peptide	NULL
.	NULL

Amino	NULL
acid	NULL
composition	NULL
and	NULL
peptide	NULL
concentrations	NULL
were	NULL
determined	NULL
using	NULL
a	NULL
Beckman	NULL
6300	NULL
amino	NULL
acid	NULL
analyzer	NULL
(	NULL
Beckman	NULL
Instruments	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
An	NULL
18-base	NULL
pair	NULL
oligonucleotide	NULL
probe	NULL
based	NULL
on	NULL
the	NULL
IFNy	NULL
response	NULL
region	NULL
(	NULL
GRR	NULL
)	NULL
within	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
FoyRI	NULL
gene	NULL
(	NULL
sense	NULL
strand	NULL
,	NULL
5'-ATGTATTTCCCAGAAA	NULL
;	NULL
-	NULL
antisense	NULL
-	NULL
strand	NULL
,	NULL
-	NULL
5'-CTTTTCTGG-GAAATA	NULL
)	NULL
was	NULL
synthesized	NULL
on	NULL
a	NULL
Beckman	NULL
Oligo	NULL
1000	NULL
DNA	NULL
synthesizer	NULL
(	NULL
Fullerton	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

A	NULL
biotinylated	NULL
derivative	NULL
of	NULL
this	NULL
probe	NULL
was	NULL
prepared	NULL
by	NULL
adding	NULL
Bictin-ON	NULL
Phosphoramidite	NULL
(	NULL
Clontech	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
.	NULL
)	NULL

at	NULL
the	NULL
5	NULL
``	NULL
end	NULL
of	NULL
the	NULL
oligonucleotide	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
.	NULL

Oligonucleotides	NULL
were	NULL
annealed	NULL
by	NULL
heating	NULL
50	NULL
ug	NULL
of	NULL
the	NULL
5	NULL
and	NULL
3	NULL
'	NULL
strands	NULL
at	NULL
95	NULL
°C	NULL
for	NULL
5	NULL
min	NULL
,	NULL
and	NULL
double-stranded	NULL
oligonucleotides	NULL
were	NULL
purified	NULL
on	NULL
a	NULL
4	NULL
%	NULL
low-melting	NULL
agarose	NULL
gel	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
20-base	NULL
pair	NULL
M67	NULL
oligonucleotide	NULL
probe	NULL
used	NULL
in	NULL
this	NULL
study	NULL
is	NULL
:	NULL
sense	NULL
strand	NULL
,	NULL
5'-GTCGACATTTCCCGTAAATC	NULL
;	NULL
and	NULL
antisense	NULL
strand	NULL
,	NULL
5'-GTAAAGGGCATTTAGCAGCT	NULL
.	NULL

Oligonucleotides	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
®°P	NULL
]	NULL
dATP	NULL
as	NULL
described	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
Five	NULL
million	NULL
primary	NULL
murine	NULL
splenocytes	NULL
or	NULL
murine	NULL
macrophages	NULL
were	NULL
plated	NULL
in	NULL
six-well	NULL
cell	NULL
culture	NULL
plates	NULL
.	NULL

The	NULL
macrophages	NULL
were	NULL
allowed	NULL
to	NULL
adhere	NULL
to	NULL
the	NULL
cell	NULL
culture	NULL
plates	NULL
for	NULL
4	NULL
h	NULL
prior	NULL
to	NULL
stimulation	NULL
.	NULL

When	NULL
IL-3-dependent	NULL
derivatives	NULL
of	NULL
the	NULL
Ba/F3	NULL
cell	NULL
line	NULL
were	NULL
used	NULL
,	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
plated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-3	NULL
,	NULL
cultured	NULL
for	NULL
4	NULL
h	NULL
,	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
either	NULL
PBS	NULL
,	NULL
400	NULL
ng	NULL
of	NULL
IL-10	NULL
,	NULL
or	NULL
4	NULL
ng	NULL
of	NULL
IFNy	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
4	NULL
ml	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
after	NULL
various	NULL
periods	NULL
of	NULL
time	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
12	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
cells	NULL
were	NULL
removed	NULL
from	NULL
the	NULL
plates	NULL
either	NULL
by	NULL
gentle	NULL
scraping	NULL
or	NULL
wash-ing	NULL
,	NULL
washed	NULL
in	NULL
ice-cold	NULL
PBS	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
cell	NULL
lysis	NULL
buffer	NULL
consisting	NULL
of	NULL
10	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
containing	NULL
10	NULL
mM	NULL
KCl	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.5	NULL
mM	NULL
phenyImethylsulfonyl	NULL
fluoride	NULL
,	NULL
25	NULL
mM	NULL
NaF	NULL
,	NULL
10	NULL
ug/ml	NULL
each	NULL
of	NULL
leupeptin	NULL
and	NULL
aprotinin	NULL
,	NULL
and	NULL
0.05	NULL
%	NULL
Nonidet	NULL
P-40	NULL
.	NULL

After	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
nuclei	NULL
were	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
at	NULL
1000	NULL
X	NULL
g	NULL
for	NULL
5	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
and	NULL
nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
by	NULL
incubation	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
with	NULL
50	NULL
pl	NULL
of	NULL
nuclear	NULL
extraction	NULL
buffer	NULL
(	NULL
20	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
containing	NULL
0.4	NULL
M	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.5	NULL
mM	NULL
phenylmethyl-sulfonyl	NULL
fluoride	NULL
,	NULL
and	NULL
10	NULL
ug/ml	NULL
each	NULL
of	NULL
leupeptin	NULL
and	NULL
aprotinin	NULL
)	NULL
.	NULL

Nuclear	NULL
membranes	NULL
were	NULL
then	NULL
pelleted	NULL
for	NULL
5	NULL
min	NULL
at	NULL
10,000	NULL
X	NULL
g	NULL
,	NULL
and	NULL
protein	NULL
concentrations	NULL
of	NULL
the	NULL
nuclear	NULL
extracts	NULL
were	NULL
determined	NULL
using	NULL
the	NULL
BCA	NULL
assay	NULL
(	NULL
Pierce	NULL
)	NULL
.	NULL

Quantitation	NULL
of	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
3	NULL
ug	NULL
of	NULL
nuclear	NULL
extracts	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
``	NULL
P-labeled	NULL
GRR	NULL
probe	NULL
as	NULL
described	NULL
(	NULL
12	NULL
,	NULL
24	NULL
)	NULL
.	NULL

Gels	NULL
were	NULL
dried	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
using	NULL
Kodak	NULL
XR5	NULL
film	NULL
(	NULL
Eastman	NULL
Kodak	NULL
Co.	NULL
,	NULL
Rochester	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
identity	NULL
of	NULL
transcription	NULL
factors	NULL
present	NULL
in	NULL
the	NULL
DNA	NULL
binding	NULL
complexes	NULL
,	NULL
supershift	NULL
experiments	NULL
were	NULL
performed	NULL
using	NULL
STAT-specific	NULL
antisera	NULL
and	NULL
control	NULL
normal	NULL
rabbit	NULL
serum	NULL
at	NULL
a	NULL
dilution	NULL
of	NULL
1:100	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
27956	NULL
STAT	NULL
Protein	NULL
Precipitation	NULL
Use	NULL
of	NULL
Biotinylated	NULL
Double-stranded	NULL
GRR	NULL
Oligonucleotide	NULL
Probes-One	NULL
hundred	NULL
ng	NULL
of	NULL
biotinylated	NULL
forms	NULL
of	NULL
the	NULL
double-stranded	NULL
GRR	NULL
probe	NULL
was	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
with	NULL
100	NULL
ul	NULL
of	NULL
streptavidin-Sepharose	NULL
.	NULL

The	NULL
Sepharose	NULL
was	NULL
washed	NULL
in	NULL
PBS	NULL
and	NULL
combined	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
nuclear	NULL
extracts	NULL
derived	NULL
from	NULL
5	NULL
X	NULL
10	NULL
``	NULL
BaMR	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
treated	NULL
for	NULL
7	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
with	NULL
100	NULL
ng/ml	NULL
murine	NULL
IL-10	NULL
.	NULL

After	NULL
incubation	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
the	NULL
Sepharose	NULL
was	NULL
pelleted	NULL
at	NULL
1000	NULL
%	NULL
g	NULL
for	NULL
5	NULL
min	NULL
and	NULL
washed	NULL
by	NULL
repeated	NULL
centrifugation	NULL
and	NULL
resuspension	NULL
in	NULL
800	NULL
pl	NULL
of	NULL
lysis	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
containing	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
10	NULL
mM	NULL
NaF	NULL
,	NULL
750	NULL
uM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
mM	NULL
phenyImethylsulfonyl	NULL
fluoride	NULL
,	NULL
and	NULL
10	NULL
pg/ml	NULL
each	NULL
of	NULL
leupeptin	NULL
and	NULL
aprotinin	NULL
)	NULL
.	NULL

The	NULL
Sepharose	NULL
was	NULL
resuspended	NULL
in	NULL
50	NULL
ul	NULL
of	NULL
2	NULL
X	NULL
buffer	NULL
containing	NULL
180	NULL
mM	NULL
2-mercaptoethanol	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
and	NULL
the	NULL
suspension	NULL
was	NULL
heated	NULL
to	NULL
70	NULL
°C	NULL
for	NULL
5	NULL
min	NULL
.	NULL

Samples	NULL
were	NULL
divided	NULL
in	NULL
half	NULL
and	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
.	NULL

Proteins	NULL
were	NULL
transferred	NULL
to	NULL
nitrocel-lulose	NULL
membranes	NULL
(	NULL
Bio-Rad	NULL
Laboratories	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
membranes	NULL
were	NULL
blocked	NULL
for	NULL
18	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
with	NULL
50	NULL
mM	NULL
Tris	NULL
buffered	NULL
physiologic	NULL
saline	NULL
(	NULL
TBS	NULL
)	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
containing	NULL
2	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
and	NULL
0.5	NULL
%	NULL
Tween	NULL
20	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
washed	NULL
in	NULL
TBS	NULL
containing	NULL
0.5	NULL
%	NULL
Tween	NULL
20	NULL
and	NULL
incubated	NULL
with	NULL
Stat1-	NULL
or	NULL
Stat8-specific	NULL
antiserum	NULL
at	NULL
a	NULL
1:8000	NULL
final	NULL
dilution	NULL
,	NULL
then	NULL
washed	NULL
again	NULL
and	NULL
incubated	NULL
with	NULL
peroxidase-conjugated	NULL
goat-anti-rabbit-IgG	NULL
at	NULL
a	NULL
dilution	NULL
of	NULL
1:7500	NULL
for	NULL
20	NULL
min	NULL
.	NULL

Antibody	NULL
binding	NULL
was	NULL
detected	NULL
by	NULL
chemiluminescence	NULL
using	NULL
the	NULL
ECL	NULL
detection	NULL
reagent	NULL
(	NULL
Amersham	NULL
Corp.	NULL
)	NULL
.	NULL

Use	NULL
of	NULL
anti-STAT	NULL
Antibodies-BaMR	NULL
,	NULL
Raw264.7	NULL
,	NULL
and	NULL
PEC	NULL
were	NULL
washed	NULL
once	NULL
in	NULL
PBS/10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
resuspended	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
lysis	NULL
buffer	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
at	NULL
4	NULL
°C	NULL
for	NULL
80	NULL
min	NULL
.	NULL

The	NULL
nuclei	NULL
were	NULL
pelleted	NULL
at	NULL
10,000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

The	NULL
protein	NULL
concentration	NULL
of	NULL
the	NULL
lysate	NULL
was	NULL
normalized	NULL
to	NULL
1.1	NULL
mg	NULL
of	NULL
total	NULL
protein	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
lysis	NULL
buffer	NULL
.	NULL

The	NULL
lysate	NULL
was	NULL
precleared	NULL
by	NULL
sequential	NULL
treatment	NULL
with	NULL
either	NULL
2	NULL
pl	NULL
of	NULL
normal	NULL
hamster	NULL
sera	NULL
(	NULL
Stat1	NULL
IP	NULL
)	NULL
or	NULL
2	NULL
ul	NULL
of	NULL
normal	NULL
rabbit	NULL
sera	NULL
(	NULL
Stat8/5	NULL
IP	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
40	NULL
pl	NULL
of	NULL
protein	NULL
G-Sepharose	NULL
(	NULL
Stat1	NULL
)	NULL
or	NULL
protein	NULL
A-Sepharose	NULL
(	NULL
Stat8/5	NULL
)	NULL
.	NULL

After	NULL
a	NULL
45-min	NULL
incubation	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
the	NULL
Sepharose	NULL
was	NULL
pelleted	NULL
,	NULL
and	NULL
10	NULL
ug	NULL
of	NULL
ATO-2F5	NULL
(	NULL
anti-Stat1	NULL
)	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
anti-Stat5	NULL
affinity-purified	NULL
rabbit	NULL
polyclonal	NULL
antibody	NULL
,	NULL
or	NULL
2	NULL
ul	NULL
of	NULL
anti-Stat3	NULL
polyclonal	NULL
sera	NULL
were	NULL
added	NULL
to	NULL
the	NULL
lysates	NULL
and	NULL
incubated	NULL
for	NULL
45	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Forty	NULL
five	NULL
ul	NULL
of	NULL
the	NULL
appropriate	NULL
Sepharose	NULL
were	NULL
added	NULL
to	NULL
each	NULL
tube	NULL
and	NULL
incubated	NULL
for	NULL
45	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

The	NULL
Sepharose	NULL
was	NULL
pelleted	NULL
and	NULL
washed	NULL
five	NULL
times	NULL
;	NULL
then	NULL
the	NULL
proteins	NULL
contained	NULL
in	NULL
the	NULL
precipitate	NULL
were	NULL
analyzed	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
Stat1	NULL
,	NULL
Stat8	NULL
,	NULL
or	NULL
Stat5	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
Western	NULL
blotting	NULL
(	NULL
utilizing	NULL
the	NULL
corresponding	NULL
mAb	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
1	NULL
ug/ml	NULL
)	NULL
.	NULL

Use	NULL
of	NULL
Biotinylated	NULL
Wild-type	NULL
or	NULL
Phosphorylated	NULL
IL-10	NULL
Receptor	NULL
Pep-tides-One	NULL
hundred	NULL
ul	NULL
of	NULL
streptavidin-Sepharose	NULL
was	NULL
incubated	NULL
for	NULL
80	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
with	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
100	NULL
uM	NULL
phosphorylated	NULL
or	NULL
nonphosphorylated	NULL
biotinylated	NULL
peptides	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
500	NULL
ul	NULL
.	NULL

Beads	NULL
were	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
(	NULL
1000	NULL
x	NULL
g	NULL
for	NULL
5	NULL
min	NULL
)	NULL
and	NULL
washed	NULL
once	NULL
with	NULL
800	NULL
ul	NULL
of	NULL
PBS	NULL
.	NULL

Fifty	NULL
million	NULL
unstimulated	NULL
BaMR	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
20	NULL
mM	NULL
HEPES	NULL
buffered	NULL
physiologic	NULL
saline	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
containing	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
10	NULL
mM	NULL
NaF	NULL
,	NULL
750	NULL
uM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
mM	NULL
phenylmeth-ylsulfonyl	NULL
fluoride	NULL
,	NULL
and	NULL
10	NULL
pg/ml	NULL
each	NULL
of	NULL
leupeptin	NULL
and	NULL
aprotinin	NULL
for	NULL
80	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
and	NULL
protein	NULL
concentration	NULL
was	NULL
determined	NULL
by	NULL
BCA	NULL
.	NULL

The	NULL
protein	NULL
concentration	NULL
of	NULL
the	NULL
lysate	NULL
was	NULL
adjusted	NULL
to	NULL
1	NULL
mg/ml	NULL
,	NULL
and	NULL
2	NULL
ml	NULL
of	NULL
lysate	NULL
were	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
with	NULL
each	NULL
of	NULL
the	NULL
peptide-Sepharose	NULL
conjugates	NULL
with	NULL
constant	NULL
mixing	NULL
.	NULL

The	NULL
Sepharose	NULL
was	NULL
pelleted	NULL
and	NULL
washed	NULL
five	NULL
times	NULL
;	NULL
then	NULL
the	NULL
proteins	NULL
contained	NULL
in	NULL
the	NULL
precipitates	NULL
were	NULL
analyzed	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
Stat3	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
Western	NULL
blotting	NULL
as	NULL
described	NULL
above	NULL
.	NULL

IL-10-dependent	NULL
STAT	NULL
Protein	NULL
Phosphorylation	NULL
in	NULL
a	NULL
Cell-free	NULL
System	NULL
One	NULL
hundred	NULL
million	NULL
BaMR	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
2	NULL
ml	NULL
of	NULL
reaction	NULL
buffer	NULL
(	NULL
10	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
containing	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
20	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
200	NULL
uM	NULL
ascorbic	NULL
acid	NULL
,	NULL
4	NULL
mM	NULL
ATP	NULL
,	NULL
2	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
phenyl-methylsulfonyl	NULL
fluoride	NULL
,	NULL
and	NULL
10	NULL
ug/ml	NULL
each	NULL
of	NULL
leupeptin	NULL
and	NULL
aprotinin	NULL
)	NULL
and	NULL
disrupted	NULL
in	NULL
a	NULL
steel	NULL
Dounce	NULL
(	NULL
82	NULL
)	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
cell	NULL
disruption	NULL
was	NULL
monitored	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
.	NULL

Homogenates	NULL
were	NULL
diluted	NULL
to	NULL
a	NULL
protein	NULL
concentration	NULL
of	NULL
40	NULL
mg/ml	NULL
!	NULL

in	NULL
reaction	NULL
buffer	NULL
,	NULL
and	NULL
450	NULL
ul	NULL
(	NULL
18	NULL
mg	NULL
total	NULL
protein	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
100	NULL
uM	NULL
phosphorylated	NULL
or	NULL
nonphosphorylated	NULL
peptides	NULL
for	NULL
45	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Subsequently	NULL
,	NULL
the	NULL
homogenates	NULL
were	NULL
treated	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
with	NULL
500	NULL
ng	NULL
of	NULL
IL-10	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
stopped	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
1.5	NULL
ml	NULL
of	NULL
lysis	NULL
buffer	NULL
.	NULL

Nuclei	NULL
were	NULL
removed	NULL
by	NULL
centrifugation	NULL
at	NULL
10,000	NULL
%	NULL
g	NULL
for	NULL
10	NULL
min	NULL
,	NULL
and	NULL
lysates	NULL
were	NULL
precleared	NULL
by	NULL
incubation	NULL
with	NULL
4	NULL
ul	NULL
of	NULL
normal	NULL
rabbit	NULL
serum	NULL
and	NULL
80	NULL
ul	NULL
of	NULL
protein	NULL
A-Sepharose	NULL
.	NULL

STAT	NULL
proteins	NULL
were	NULL
precipi-	NULL
Stat3	NULL
Recruitment	NULL
by	NULL
the	NULL
IL-10	NULL
Receptor	NULL
BaF3	NULL
BaMR	NULL
RAW264.7	NULL
PEC	NULL
Spleen	NULL
|	NULL
I	NULL
T	NULL
1T	NULL
e	NULL
|	NULL
A-_	NULL
-=	NULL
4	NULL
gJ—	NULL
bel	NULL
use	NULL
E	NULL
ta	NULL
[	NULL
J	NULL
tap	NULL
a	NULL
T	NULL
P	NULL
f	NULL
T	NULL
F	NULL
i	NULL
CF	NULL
i	NULL
CF	NULL
i	NULL
l	NULL
g	NULL
»	NULL
~	NULL
g	NULL
°	NULL
-	NULL
=	NULL
o	NULL
-	NULL
<	NULL
%	NULL
0	NULL
-	NULL
<	NULL
i	NULL
o	NULL
<	NULL
3	NULL
E	NULL
]	NULL
3	NULL
3	NULL
3	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

IL-10	NULL
induces	NULL
formation	NULL
of	NULL
three	NULL
distinct	NULL
DNA	NULL
binding	NULL
complexes	NULL
as	NULL
determined	NULL
by	NULL
EMSA	NULL
.	NULL

Five	NULL
million	NULL
cultured	NULL
Ba/F3	NULL
cells	NULL
(	NULL
IL-10	NULL
receptor-negative	NULL
pro-B	NULL
cells	NULL
)	NULL
,	NULL
cultured	NULL
BaMR	NULL
cells	NULL
(	NULL
Ba/F3	NULL
cells	NULL
stably	NULL
expressing	NULL
6800	NULL
copies	NULL
of	NULL
the	NULL
ligand	NULL
binding	NULL
chain	NULL
of	NULL
IL-10	NULL
receptor	NULL
)	NULL
,	NULL
cultured	NULL
RAW264.7	NULL
macrophages	NULL
,	NULL
primary	NULL
peritoneal	NULL
exudate	NULL
macrophages	NULL
(	NULL
PEC	NULL
)	NULL
or	NULL
primary	NULL
murine	NULL
splenocytes	NULL
were	NULL
treated	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
4	NULL
ml	NULL
with	NULL
medium	NULL
,	NULL
recombinant	NULL
murine	NULL
IL-10	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
,	NULL
or	NULL
recombinant	NULL
murine	NULL
IFNy	NULL
(	NULL
1	NULL
ng/ml	NULL
)	NULL
for	NULL
7	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

Each	NULL
reaction	NULL
used	NULL
3	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
protein	NULL
and	NULL
a	NULL
*°P-labeled	NULL
18-base	NULL
pair	NULL
oligonucleotide	NULL
probe	NULL
derived	NULL
from	NULL
the	NULL
GRR	NULL
of	NULL
the	NULL
FoyRI	NULL
gene	NULL
.	NULL

DNA	NULL
:	NULL
protein	NULL
complexes	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
6	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
.	NULL

tated	NULL
using	NULL
1	NULL
pl	NULL
of	NULL
Stat3-specific	NULL
antiserum	NULL
and	NULL
100	NULL
ul	NULL
of	NULL
protein	NULL
A-Sepharose	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
washed	NULL
five	NULL
times	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
Western	NULL
blotting	NULL
using	NULL
the	NULL
phosphotyrosine-specific	NULL
RC-20	NULL
mAb	NULL
.	NULL

To	NULL
control	NULL
for	NULL
protein	NULL
loading	NULL
,	NULL
membranes	NULL
were	NULL
stripped	NULL
according	NULL
to	NULL
the	NULL
ECL	NULL
protocol	NULL
and	NULL
then	NULL
reprobed	NULL
with	NULL
Stat3	NULL
antisera	NULL
.	NULL

RESULTS	NULL
IL-10	NULL
Treatment	NULL
of	NULL
Cells	NULL
Leads	NULL
to	NULL
the	NULL
Generation	NULL
of	NULL
Multiple	NULL
DNA	NULL
Binding	NULL
Species-IL-10	NULL
treatment	NULL
of	NULL
IL-10	NULL
receptor-expressing	NULL
cultured	NULL
and	NULL
primary	NULL
cells	NULL
(	NULL
BaMR	NULL
,	NULL
RAW264.7	NULL
,	NULL
PEC	NULL
,	NULL
and	NULL
splenocytes	NULL
)	NULL
resulted	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
at	NULL
least	NULL
three	NULL
electrophoretically	NULL
distinct	NULL
DNA	NULL
binding	NULL
complexes	NULL
(	NULL
denoted	NULL
as	NULL
bands	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
)	NULL
that	NULL
can	NULL
be	NULL
detected	NULL
in	NULL
nuclear	NULL
extracts	NULL
within	NULL
minutes	NULL
after	NULL
ligand	NULL
addition	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

These	NULL
complexes	NULL
were	NULL
visualized	NULL
using	NULL
an	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
that	NULL
used	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
GRR	NULL
probe	NULL
)	NULL
previously	NULL
shown	NULL
to	NULL
be	NULL
recognized	NULL
by	NULL
several	NULL
different	NULL
activated	NULL
STAT	NULL
complexes	NULL
.	NULL

The	NULL
EMSA	NULL
complexes	NULL
induced	NULL
by	NULL
IL-10	NULL
were	NULL
more	NULL
complex	NULL
than	NULL
those	NULL
induced	NULL
following	NULL
IFNy	NULL
treatment	NULL
of	NULL
the	NULL
same	NULL
cells	NULL
.	NULL

None	NULL
of	NULL
the	NULL
nuclear	NULL
extracts	NULL
derived	NULL
from	NULL
either	NULL
unstimulated	NULL
receptor-bearing	NULL
cells	NULL
or	NULL
IL-10-treated	NULL
cells	NULL
that	NULL
lack	NULL
the	NULL
IL-10	NULL
receptor	NULL
(	NULL
Ba/F3	NULL
)	NULL
showed	NULL
binding	NULL
to	NULL
the	NULL
GRR	NULL
probe	NULL
.	NULL

The	NULL
appearance	NULL
of	NULL
the	NULL
IL-10-induced	NULL
DNA	NULL
containing	NULL
complexes	NULL
in	NULL
cell	NULL
nuclei	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
time	NULL
of	NULL
stimulation	NULL
and	NULL
the	NULL
amount	NULL
of	NULL
IL-10	NULL
used	NULL
.	NULL

IL-10-induced	NULL
gel	NULL
shift	NULL
complexes	NULL
were	NULL
first	NULL
observed	NULL
in	NULL
the	NULL
nucleus	NULL
after	NULL
1-3	NULL
min	NULL
,	NULL
were	NULL
maximal	NULL
after	NULL
7-15	NULL
min	NULL
,	NULL
and	NULL
disappeared	NULL
60	NULL
min	NULL
after	NULL
IL-10	NULL
addition	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
kinetics	NULL
were	NULL
distinct	NULL
from	NULL
those	NULL
of	NULL
the	NULL
IFN	NULL
y-induced	NULL
complexes	NULL
that	NULL
appeared	NULL
more	NULL
rapidly	NULL
were	NULL
detectable	NULL
in	NULL
the	NULL
nucleus	NULL
after	NULL
only	NULL
1	NULL
min	NULL
of	NULL
treatment	NULL
)	NULL
and	NULL
that	NULL
were	NULL
still	NULL
detectable	NULL
in	NULL
the	NULL
nucleus	NULL
2-3	NULL
h	NULL
after	NULL
stimulation	NULL
.	NULL

Thus	NULL
,	NULL
IL-10	NULL
induces	NULL
the	NULL
activation	NULL
of	NULL
multiple	NULL
DNA	NULL
binding	NULL
complexes	NULL
with	NULL
STAT-like	NULL
DNA	NULL
binding	NULL
specificity	NULL
in	NULL
both	NULL
cultured	NULL
and	NULL
primary	NULL
IL-10-responsive	NULL
cells	NULL
.	NULL

Stat1	NULL
and	NULL
Stat3	NULL
Are	NULL
Activated	NULL
in	NULL
All	NULL
IL-10-treated	NULL
Cells	NULL
,	NULL
and	NULL
Stat5	NULL
Is	NULL
Additionally	NULL
Activated	NULL
in	NULL
IL-10-treated	NULL
Pro-B	NULL
Cells	NULL
Expressing	NULL
the	NULL
IL-10	NULL
Receptor-Supershift	NULL
experiments	NULL
performed	NULL
on	NULL
all	NULL
IL-10-treated	NULL
cells	NULL
revealed	NULL
that	NULL
ligand	NULL
induced	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Stat3	NULL
Recruitment	NULL
by	NULL
the	NULL
IL-10	NULL
Receptor	NULL
A	NULL
Lane	NULL
14	NULL
20	NULL
38	NULL
4	NULL
506	NULL
7	NULL
PEC	NULL
«	NULL
*	NULL
>	NULL
I	NULL
)	NULL
&	NULL
uon	NULL
[	NULL
non	NULL
Hels	NULL
ess	NULL
1218	NULL
pels	NULL
S12IS	NULL
It	NULL
xt	NULL
Ab	NULL
:	NULL
&	NULL
®	NULL
Suon	NULL
HelS	NULL
cles	NULL
gielg	NULL
pies	NULL
121g	NULL
EeIS	NULL
L_	NULL
]	NULL
PBS	NULL
IL-10	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Statl	NULL
and	NULL
Stat3	NULL
are	NULL
activated	NULL
in	NULL
all	NULL
IL-10-treated	NULL
cells	NULL
,	NULL
and	NULL
Stato	NULL
is	NULL
additionally	NULL
activated	NULL
in	NULL
IL-10-treated	NULL
pro-B	NULL
cells	NULL
expressing	NULL
the	NULL
IL-10	NULL
receptor	NULL
.	NULL

Primary	NULL
murine	NULL
peritoneal	NULL
macrophages	NULL
(	NULL
PEC	NULL
)	NULL
(	NULL
A	NULL
)	NULL
or	NULL
cultured	NULL
IL-10	NULL
receptor-positive	NULL
BaMR	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
were	NULL
treated	NULL
either	NULL
with	NULL
PBS	NULL
or	NULL
recombinant	NULL
murine	NULL
IL-10	NULL
(	NULL
100	NULL
ng/ml	NULL
for	NULL
7	NULL
min	NULL
)	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

Three	NULL
ug	NULL
of	NULL
each	NULL
extract	NULL
were	NULL
assayed	NULL
for	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
antisera	NULL
specific	NULL
for	NULL
Stat1	NULL
,	NULL
Stat2	NULL
,	NULL
Stat8	NULL
,	NULL
Statd4	NULL
,	NULL
or	NULL
Stat5	NULL
at	NULL
final	NULL
concentrations	NULL
of	NULL
1:100	NULL
using	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1.	NULL
the	NULL
activation	NULL
of	NULL
both	NULL
Statl	NULL
and	NULL
Stat3	NULL
.	NULL

Using	NULL
peritoneal	NULL
macrophages	NULL
as	NULL
an	NULL
example	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
,	NULL
bands	NULL
B	NULL
and	NULL
C	NULL
were	NULL
supershifted	NULL
by	NULL
Stat1l-specific	NULL
antiserum	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
,	NULL
and	NULL
bands	NULL
A	NULL
and	NULL
B	NULL
were	NULL
supershifted	NULL
by	NULL
Stat3-specific	NULL
antiserum	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
a	NULL
combination	NULL
of	NULL
Statl	NULL
and	NULL
Stat3	NULL
antisera	NULL
completely	NULL
supershifted	NULL
all	NULL
three	NULL
IL-10-induced	NULL
EMSA	NULL
complexes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Stat2	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
Statd4	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
and	NULL
Stato	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
antisera	NULL
did	NULL
not	NULL
influence	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
EMSA	NULL
complexes	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
IL-10-induced	NULL
bands	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
represent	NULL
a	NULL
Stat3	NULL
homodimer	NULL
,	NULL
Stat1/Stat3	NULL
heterodimer	NULL
,	NULL
and	NULL
a	NULL
Statl	NULL
homodimer	NULL
,	NULL
respectively	NULL
,	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
using	NULL
RAW264.7	NULL
cells	NULL
and	NULL
splenocytes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
validity	NULL
of	NULL
these	NULL
observations	NULL
was	NULL
confirmed	NULL
by	NULL
the	NULL
demonstration	NULL
that	NULL
phosphorylated	NULL
forms	NULL
of	NULL
Statl	NULL
and	NULL
Stat3	NULL
could	NULL
be	NULL
precipitated	NULL
with	NULL
Sepharose-associated	NULL
biotinylated	NULL
double-stranded	NULL
GRR	NULL
probe	NULL
from	NULL
IL-10-treated	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
Horvath	NULL
et	NULL
al	NULL
.	NULL

(	NULL
33	NULL
)	NULL
demonstrated	NULL
that	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
M67	NULL
)	NULL
derived	NULL
from	NULL
the	NULL
serum-inducible	NULL
element	NULL
of	NULL
c-fos	NULL
binds	NULL
to	NULL
activated	NULL
Stat3	NULL
with	NULL
higher	NULL
affinity	NULL
than	NULL
activated	NULL
Statl	NULL
.	NULL

When	NULL
IL-10	NULL
EMSAs	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
M67	NULL
probe	NULL
,	NULL
the	NULL
resulting	NULL
gel	NULL
shift	NULL
pattern	NULL
showed	NULL
a	NULL
much	NULL
higher	NULL
proportion	NULL
of	NULL
band	NULL
A	NULL
compared	NULL
to	NULL
GRR	NULL
gel	NULL
shifts	NULL
.	NULL

The	NULL
band	NULL
A	NULL
observed	NULL
with	NULL
the	NULL
M67	NULL
probe	NULL
was	NULL
completely	NULL
supershifted	NULL
by	NULL
Stat3-specific	NULL
antiserum	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
IL-10	NULL
induces	NULL
activation	NULL
of	NULL
Stat1	NULL
and	NULL
Stat3	NULL
in	NULL
all	NULL
cells	NULL
expressing	NULL
functionally	NULL
active	NULL
IL-10	NULL
receptors	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
supershift	NULL
analysis	NULL
performed	NULL
on	NULL
nuclear	NULL
extracts	NULL
of	NULL
IL-10-treated	NULL
Ba/F3	NULL
pro-B	NULL
cells	NULL
that	NULL
stably	NULL
express	NULL
the	NULL
murine	NULL
IL-10	NULL
receptor	NULL
(	NULL
BaMR	NULL
cells	NULL
)	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
additional	NULL
DNA	NULL
binding	NULL
component	NULL
that	NULL
displayed	NULL
a	NULL
mobility	NULL
that	NULL
was	NULL
identical	NULL
to	NULL
the	NULL
Stat3	NULL
homodimer	NULL
but	NULL
which	NULL
was	NULL
not	NULL
recognized	NULL
by	NULL
anti-Stat3	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

This	NULL
analysis	NULL
revealed	NULL
that	NULL
band	NULL
A	NULL
was	NULL
only	NULL
partially	NULL
supershifted	NULL
with	NULL
Stat3-specific	NULL
antiserum	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
band	NULL
was	NULL
also	NULL
partially	NULL
supershifted	NULL
with	NULL
antiserum	NULL
specific	NULL
for	NULL
Stato	NULL
(	NULL
Zane	NULL
7	NULL
)	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
Stats-	NULL
and	NULL
Stat5-specific	NULL
antisera	NULL
completely	NULL
supershifted	NULL
band	NULL
A	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
a	NULL
mixture	NULL
of	NULL
Statl-	NULL
,	NULL
Stat3-	NULL
,	NULL
and	NULL
Stat5-specific	NULL
antisera	NULL
was	NULL
able	NULL
to	NULL
com	NULL
27957	NULL
Stati	NULL
M	NULL
,	NULL
(	NULL
kDa	NULL
)	NULL
118	NULL
86	NULL
-	NULL
p-	NULL
p-	NULL
ped	NULL
Statd	NULL
M	NULL
,	NULL
(	NULL
kDa	NULL
)	NULL
118	NULL
86	NULL
-	NULL
«	NULL
en	NULL
tcm	NULL
ge-	NULL
»	NULL
Stat5	NULL
M.	NULL
(	NULL
kDa	NULL
)	NULL
118	NULL
hand	NULL
_-	NULL
gman	NULL
86	NULL
NS	NULL
aSTAT	NULL
NS	NULL
STAT	NULL
NS	NULL
aSTAT	NULL
Ex_EL_____j	NULL
BaMR	NULL
Raw264.7	NULL
PEC	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Cellular	NULL
levels	NULL
of	NULL
Stat1	NULL
,	NULL
Stat3	NULL
,	NULL
and	NULL
Stat5	NULL
expression	NULL
are	NULL
roughly	NULL
equivalent	NULL
in	NULL
all	NULL
cell	NULL
types	NULL
tested	NULL
.	NULL

BaMR	NULL
,	NULL
Raw264.7	NULL
,	NULL
and	NULL
PEC	NULL
cells	NULL
were	NULL
lysed	NULL
,	NULL
and	NULL
the	NULL
protein	NULL
concentration	NULL
of	NULL
the	NULL
lysate	NULL
was	NULL
adjusted	NULL
to	NULL
1.1	NULL
mg/ml	NULL
.	NULL

One	NULL
milliliter	NULL
of	NULL
lysate	NULL
was	NULL
incubated	NULL
with	NULL
the	NULL
appropriate	NULL
normal	NULL
sera	NULL
(	NULL
NS	NULL
)	NULL
or	NULL
antibodies	NULL
specific	NULL
for	NULL
Statl	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
,	NULL
Stat3	NULL
(	NULL
middle	NULL
panel	NULL
)	NULL
,	NULL
or	NULL
Stat5	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
.	NULL

Following	NULL
immuno-precipitation	NULL
,	NULL
the	NULL
precipitates	NULL
were	NULL
analyzed	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
Stat1	NULL
,	NULL
Stat8	NULL
,	NULL
or	NULL
Stat5	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
Western	NULL
blotting	NULL
utilizing	NULL
the	NULL
corresponding	NULL
monoclonal	NULL
antibody	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
1	NULL
ug/ml	NULL
.	NULL

pletely	NULL
supershift	NULL
all	NULL
EMSA	NULL
complexes	NULL
observed	NULL
in	NULL
IL-10-treated	NULL
BaMR	NULL
cells	NULL
(	NULL
Zane	NULL
9	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
BaMR	NULL
cells	NULL
respond	NULL
to	NULL
IL-10	NULL
by	NULL
activating	NULL
Stat5	NULL
in	NULL
addition	NULL
to	NULL
Statl	NULL
and	NULL
Stat3	NULL
.	NULL

These	NULL
results	NULL
thus	NULL
demonstrate	NULL
that	NULL
IL-10	NULL
activates	NULL
the	NULL
transcription	NULL
factors	NULL
Statl	NULL
and	NULL
Stat3	NULL
in	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
IL-10	NULL
receptor-bearing	NULL
cell	NULL
types	NULL
and	NULL
,	NULL
in	NULL
addition	NULL
,	NULL
can	NULL
activate	NULL
Stat5	NULL
in	NULL
a	NULL
cell-restricted	NULL
manner	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
the	NULL
difference	NULL
in	NULL
EMSA	NULL
complex	NULL
formation	NULL
observed	NULL
in	NULL
BaMR	NULL
cells	NULL
compared	NULL
to	NULL
other	NULL
cells	NULL
was	NULL
attributable	NULL
to	NULL
differences	NULL
in	NULL
cellular	NULL
expression	NULL
of	NULL
Stat1	NULL
,	NULL
Stat3	NULL
,	NULL
or	NULL
Stat5	NULL
,	NULL
we	NULL
performed	NULL
immunoprecipitation/Western	NULL
blot	NULL
analyses	NULL
on	NULL
each	NULL
cell	NULL
type	NULL
using	NULL
STAT	NULL
protein-specific	NULL
antibodies	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Statl	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
,	NULL
Stat3	NULL
(	NULL
middle	NULL
panel	NULL
)	NULL
and	NULL
Stat5	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
were	NULL
expressed	NULL
at	NULL
roughly	NULL
equivalent	NULL
levels	NULL
in	NULL
BaMR	NULL
,	NULL
RAW264.7	NULL
,	NULL
and	NULL
PEC	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
differential	NULL
IL-10-dependent	NULL
activation	NULL
of	NULL
Stat5	NULL
seen	NULL
in	NULL
BaMR	NULL
cells	NULL
is	NULL
not	NULL
due	NULL
to	NULL
the	NULL
enhanced	NULL
expression	NULL
of	NULL
this	NULL
particular	NULL
STAT	NULL
protein	NULL
.	NULL

Two	NULL
Tyrosine	NULL
Residues	NULL
at	NULL
Positions	NULL
427	NULL
and	NULL
477	NULL
in	NULL
the	NULL
Intracellular	NULL
Domain	NULL
of	NULL
the	NULL
Murine	NULL
IL-10	NULL
Receptor	NULL
Are	NULL
Critical	NULL
for	NULL
Ligand-dependent	NULL
Stat3	NULL
Activation-We	NULL
next	NULL
investigated	NULL
whether	NULL
Statl	NULL
,	NULL
Stat3	NULL
,	NULL
and	NULL
Stat5	NULL
were	NULL
recruited	NULL
to	NULL
the	NULL
IL-10	NULL
receptor	NULL
in	NULL
a	NULL
manner	NULL
analogous	NULL
to	NULL
that	NULL
used	NULL
in	NULL
IFNy	NULL
signaling	NULL
,	NULL
i.e	NULL
.	NULL

through	NULL
interaction	NULL
of	NULL
specific	NULL
STAT	NULL
proteins	NULL
with	NULL
a	NULL
specific	NULL
phosphotyrosine-containing	NULL
sequence	NULL
within	NULL
the	NULL
intracellular	NULL
domain	NULL
of	NULL
the	NULL
receptor	NULL
.	NULL

The	NULL
ligand	NULL
binding	NULL
subunit	NULL
of	NULL
the	NULL
murine	NULL
IL-10	NULL
receptor	NULL
intracellular	NULL
domain	NULL
contains	NULL
four	NULL
tyrosine	NULL
residues	NULL
at	NULL
positions	NULL
374	NULL
,	NULL
396	NULL
,	NULL
427	NULL
,	NULL
and	NULL
477	NULL
.	NULL

Two	NULL
of	NULL
these	NULL
,	NULL
Tyr*	NULL
``	NULL
and	NULL
Tyr*	NULL
'	NULL
``	NULL
,	NULL
are	NULL
conserved	NULL
in	NULL
human	NULL
and	NULL
murine	NULL
IL-10	NULL
receptors	NULL
(	NULL
1	NULL
)	NULL
.	NULL

We	NULL
,	NULL
therefore	NULL
,	NULL
generated	NULL
a	NULL
family	NULL
of	NULL
IL-10	NULL
receptor	NULL
deletion	NULL
or	NULL
point	NULL
mutants	NULL
that	NULL
lacked	NULL
different	NULL
combinations	NULL
of	NULL
intracellular	NULL
domain	NULL
tyrosine	NULL
residues	NULL
and	NULL
stably	NULL
expressed	NULL
each	NULL
mutant	NULL
or	NULL
wild-type	NULL
receptor	NULL
in	NULL
murine	NULL
Ba/F3	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
27958	NULL
A	NULL
Wild	NULL
Type	NULL
and	NULL
Mutant	NULL
IL-10	NULL
Receptors	NULL
Lane	NULL
:	NULL
__	NULL
1	NULL
_	NULL
20	NULL
3	NULL
40	NULL
50	NULL
600	NULL
7	NULL
8	NULL
t	NULL
?	NULL

3	NULL
4	NULL
adk1L	NULL
PMM	NULL
l	NULL
ALZPA	NULL
ALLPA	NULL
PLP-e8eV	NULL
6SS-20pPV	NULL
deL¥/LGFPA	NULL
I	NULL
:	NULL
Stimulus	NULL
:	NULL
L	NULL
__	NULL
_	NULL
LLL	NULL
None	NULL
IL-10	NULL
None	NULL
.	NULL

IL	NULL
;	NULL
10	NULL
B	NULL
A402559	NULL
Mutant	NULL
IL-10	NULL
Receptor	NULL
Lane	NULL
:	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
®	NULL
#	NULL
%	NULL
*	NULL
A	NULL
-g-	NULL
L_	NULL
None	NULL
I-10	NULL
aSTAT	NULL
>	NULL
>	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
1/5	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Tyrosine	NULL
residues	NULL
427	NULL
and	NULL
477	NULL
in	NULL
the	NULL
murine	NULL
IL-10	NULL
receptor	NULL
intracellular	NULL
domain	NULL
are	NULL
redundant	NULL
for	NULL
IL-10-dependent	NULL
Stat3	NULL
activation	NULL
.	NULL

In	NULL
A	NULL
,	NULL
EMSAs	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
on	NULL
nuclear	NULL
extracts	NULL
derived	NULL
from	NULL
PBS	NULL
or	NULL
IL-10-treated	NULL
Ba/F3	NULL
cells	NULL
expressing	NULL
either	NULL
wild-type	NULL
IL-10	NULL
receptor	NULL
(	NULL
BaMR	NULL
)	NULL
,	NULL
the	NULL
IL-10	NULL
receptor	NULL
deletion	NULL
mutants	NULL
A282-414	NULL
and	NULL
A402-559	NULL
,	NULL
the	NULL
IL-10	NULL
receptor	NULL
point	NULL
mutants	NULL
Y427F	NULL
and	NULL
Y477F	NULL
,	NULL
or	NULL
a	NULL
mutant	NULL
IL-10	NULL
receptor	NULL
containing	NULL
phenylalanine	NULL
substitutions	NULL
for	NULL
both	NULL
Tyr*	NULL
``	NULL
and	NULL
Tyr*	NULL
``	NULL
``	NULL
.	NULL

In	NULL
B	NULL
,	NULL
supershift	NULL
analyses	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
on	NULL
nuclear	NULL
extracts	NULL
derived	NULL
from	NULL
PBS	NULL
or	NULL
IL-10-treated	NULL
Ba/F3	NULL
cells	NULL
expressing	NULL
the	NULL
IL-10	NULL
receptor	NULL
deletion	NULL
mutant	NULL
A402-559	NULL
.	NULL

For	NULL
this	NULL
analysis	NULL
,	NULL
7	NULL
pg	NULL
of	NULL
nuclear	NULL
extract	NULL
were	NULL
assayed	NULL
for	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
STAT-specific	NULL
antisera	NULL
.	NULL

cells	NULL
.	NULL

As	NULL
determined	NULL
by	NULL
Scatchard	NULL
analysis	NULL
,	NULL
the	NULL
resulting	NULL
cell	NULL
lines	NULL
expressed	NULL
comparable	NULL
levels	NULL
of	NULL
IL-10	NULL
receptor	NULL
that	NULL
displayed	NULL
identical	NULL
ligand	NULL
binding	NULL
affinities	NULL
in	NULL
the	NULL
range	NULL
of	NULL
33-39	NULL
pM	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Whereas	NULL
unstimulated	NULL
receptor	NULL
bearing	NULL
cells	NULL
did	NULL
not	NULL
induce	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
the	NULL
appropriate	NULL
gel	NULL
shift	NULL
complexes	NULL
were	NULL
induced	NULL
in	NULL
IL-10-stimulated	NULL
Ba/F3	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
wild-type	NULL
IL-10	NULL
receptor	NULL
cDNA	NULL
and	NULL
which	NULL
expressed	NULL
6300	NULL
receptors/cell	NULL
,	NULL
i.e	NULL
.	NULL

BaMR	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Ba/F3	NULL
cells	NULL
expressing	NULL
a	NULL
mutant	NULL
IL-10	NULL
receptor	NULL
lacking	NULL
residues	NULL
282-414	NULL
that	NULL
thereby	NULL
deletes	NULL
tyrosines	NULL
374	NULL
and	NULL
396	NULL
(	NULL
6300	NULL
receptors/cell	NULL
)	NULL
also	NULL
produced	NULL
DNA	NULL
binding	NULL
factors	NULL
in	NULL
response	NULL
to	NULL
IL-10	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
cells	NULL
expressing	NULL
the	NULL
IL-10	NULL
receptor	NULL
mutant	NULL
lacking	NULL
residues	NULL
402-559	NULL
that	NULL
thereby	NULL
deletes	NULL
Tyr	NULL
``	NULL
and	NULL
Tyr®	NULL
``	NULL
``	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lane	NULL
4	NULL
;	NULL
9600	NULL
receptors/cell	NULL
)	NULL
were	NULL
severely	NULL
impaired	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
manifest	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

IL-10	NULL
stimulation	NULL
of	NULL
these	NULL
cells	NULL
failed	NULL
to	NULL
produce	NULL
band	NULL
B	NULL
but	NULL
induced	NULL
detectable	NULL
quantities	NULL
of	NULL
bands	NULL
A	NULL
and	NULL
C.	NULL
To	NULL
determine	NULL
the	NULL
STAT	NULL
content	NULL
of	NULL
the	NULL
band	NULL
A	NULL
and	NULL
C	NULL
complexes	NULL
induced	NULL
in	NULL
cells	NULL
expressing	NULL
the	NULL
A402-559	NULL
deletion	NULL
mu-tant	NULL
,	NULL
supershift	NULL
analyses	NULL
were	NULL
performed	NULL
on	NULL
IL-10-treated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

As	NULL
before	NULL
,	NULL
treatment	NULL
of	NULL
mutant	NULL
receptor-bearing	NULL
cells	NULL
with	NULL
IL-10	NULL
resulted	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
two	NULL
EMSA	NULL
complexes	NULL
with	NULL
mobilities	NULL
that	NULL
corresponded	NULL
to	NULL
bands	NULL
A	NULL
and	NULL
C	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
.	NULL

Band	NULL
C	NULL
was	NULL
supershifted	NULL
by	NULL
Statl-specific	NULL
antisera	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Band	NULL
A	NULL
was	NULL
completely	NULL
supershifted	NULL
by	NULL
anti-Stat5	NULL
serum	NULL
(	NULL
Zane	NULL
7	NULL
)	NULL
and	NULL
not	NULL
by	NULL
antisera	NULL
specific	NULL
for	NULL
any	NULL
other	NULL
STAT	NULL
protein	NULL
(	NULL
lanes	NULL
3-6	NULL
)	NULL
,	NULL
including	NULL
Stat3	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
combination	NULL
Stat3	NULL
Recruitment	NULL
by	NULL
the	NULL
IL-10	NULL
Receptor	NULL
of	NULL
antisera	NULL
specific	NULL
for	NULL
Statl	NULL
and	NULL
Stat5	NULL
completely	NULL
supershifted	NULL
all	NULL
EMSA	NULL
complexes	NULL
present	NULL
in	NULL
the	NULL
lane	NULL
.	NULL

Thus	NULL
,	NULL
IL-10-dependent	NULL
Statl	NULL
and	NULL
Stat5	NULL
activation	NULL
is	NULL
promoted	NULL
by	NULL
IL-10	NULL
receptor	NULL
sequences	NULL
that	NULL
are	NULL
distinct	NULL
from	NULL
those	NULL
required	NULL
for	NULL
activation	NULL
of	NULL
Stat3	NULL
.	NULL

To	NULL
explore	NULL
the	NULL
specific	NULL
roles	NULL
of	NULL
the	NULL
tyrosine	NULL
residues	NULL
within	NULL
the	NULL
402-559	NULL
region	NULL
of	NULL
the	NULL
IL-10	NULL
receptor	NULL
,	NULL
we	NULL
used	NULL
Ba/F3	NULL
cells	NULL
that	NULL
stably	NULL
expressed	NULL
receptor	NULL
point	NULL
mutants	NULL
that	NULL
either	NULL
lacked	NULL
one	NULL
or	NULL
both	NULL
tyrosines	NULL
at	NULL
positions	NULL
427	NULL
and	NULL
477	NULL
.	NULL

Wild-type	NULL
re-ceptor-induced	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
observed	NULL
in	NULL
IL-10-treated	NULL
Ba/F3	NULL
cells	NULL
that	NULL
expressed	NULL
either	NULL
IL-10	NULL
receptor	NULL
single	NULL
point	NULL
mutant	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
Y427F	NULL
or	NULL
Y477F	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggested	NULL
that	NULL
Stat3	NULL
activation	NULL
was	NULL
either	NULL
not	NULL
dependent	NULL
on	NULL
receptor	NULL
intracellular	NULL
domain	NULL
tyrosine	NULL
residues	NULL
or	NULL
that	NULL
IL-10	NULL
receptor	NULL
tyrosines	NULL
Tyr*	NULL
``	NULL
and	NULL
Tyr*	NULL
'	NULL
``	NULL
could	NULL
serve	NULL
a	NULL
redundant	NULL
STAT	NULL
recruitment	NULL
function	NULL
.	NULL

To	NULL
explore	NULL
this	NULL
possibility	NULL
,	NULL
cells	NULL
bearing	NULL
an	NULL
IL-10	NULL
receptor	NULL
mutant	NULL
with	NULL
phenylalanine	NULL
substitutions	NULL
for	NULL
both	NULL
Tyr*	NULL
``	NULL
and	NULL
Tyr*	NULL
``	NULL
``	NULL
were	NULL
prepared	NULL
(	NULL
2500	NULL
receptors/cell	NULL
)	NULL
.	NULL

These	NULL
cells	NULL
failed	NULL
to	NULL
produce	NULL
significant	NULL
amounts	NULL
of	NULL
Stat3-dependent	NULL
DNA	NULL
binding	NULL
complexes	NULL
when	NULL
exposed	NULL
to	NULL
IL-10	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
Stat3	NULL
activation	NULL
requires	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
Y427	NULL
or	NULL
Y477	NULL
in	NULL
the	NULL
intracellular	NULL
domain	NULL
of	NULL
the	NULL
ligand	NULL
binding	NULL
component	NULL
of	NULL
the	NULL
IL-10	NULL
receptor	NULL
,	NULL
and	NULL
at	NULL
least	NULL
some	NULL
of	NULL
the	NULL
IL-10-dependent	NULL
activation	NULL
of	NULL
Statl	NULL
and	NULL
Stat5	NULL
occurs	NULL
at	NULL
a	NULL
site	NULL
independent	NULL
of	NULL
these	NULL
two	NULL
tyrosine	NULL
residues	NULL
.	NULL

To	NULL
validate	NULL
the	NULL
physiologic	NULL
relevance	NULL
of	NULL
these	NULL
results	NULL
,	NULL
the	NULL
cell	NULL
lines	NULL
expressing	NULL
the	NULL
various	NULL
IL-10	NULL
receptor	NULL
mutants	NULL
were	NULL
monitored	NULL
for	NULL
the	NULL
capacity	NULL
to	NULL
manifest	NULL
IL-10-dependent	NULL
proliferative	NULL
responses	NULL
.	NULL

Ba/F3	NULL
cells	NULL
lacking	NULL
IL-10	NULL
receptors	NULL
did	NULL
not	NULL
proliferate	NULL
in	NULL
response	NULL
to	NULL
IL-10	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
cells	NULL
expressing	NULL
IL-10	NULL
receptors	NULL
that	NULL
supported	NULL
the	NULL
generation	NULL
of	NULL
an	NULL
IL-10-dependent	NULL
,	NULL
Stat3	NULL
containing	NULL
gel	NULL
shift	NULL
complex	NULL
(	NULL
BaMR	NULL
,	NULL
A282-414	NULL
,	NULL
Y427F	NULL
,	NULL
and	NULL
Y477F	NULL
)	NULL
proliferated	NULL
when	NULL
exposed	NULL
to	NULL
IL-10	NULL
(	NULL
29	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
cells	NULL
bearing	NULL
IL-10	NULL
receptor	NULL
mutants	NULL
that	NULL
were	NULL
unable	NULL
to	NULL
activate	NULL
Stat3	NULL
in	NULL
response	NULL
to	NULL
ligand	NULL
(	NULL
A402-559	NULL
and	NULL
Y427F/Y477F	NULL
)	NULL
failed	NULL
to	NULL
mount	NULL
a	NULL
proliferative	NULL
response	NULL
to	NULL
IL-10	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
established	NULL
a	NULL
direct	NULL
correlation	NULL
between	NULL
the	NULL
IL-10	NULL
receptor	NULL
tyrosine	NULL
residues	NULL
needed	NULL
for	NULL
Stat3	NULL
activation	NULL
and	NULL
biologic	NULL
response	NULL
induction	NULL
.	NULL

Demonstration	NULL
of	NULL
an	NULL
Interaction	NULL
between	NULL
Stat3	NULL
and	NULL
IL-10	NULL
Receptor	NULL
Peptides	NULL
Containing	NULL
Phosphorylated	NULL
Forms	NULL
of	NULL
Tyr®	NULL
``	NULL
and	NULL
Tyr®	NULL
``	NULL
'-To	NULL
investigate	NULL
whether	NULL
Statl	NULL
and/or	NULL
Stat3	NULL
interacted	NULL
with	NULL
IL-10	NULL
receptor	NULL
sequences	NULL
containing	NULL
Tyr*	NULL
``	NULL
'	NULL
or	NULL
Tyr*	NULL
``	NULL
``	NULL
,	NULL
we	NULL
performed	NULL
coprecipitation	NULL
analyses	NULL
using	NULL
biotinylated	NULL
12	NULL
amino	NULL
acid	NULL
peptides	NULL
based	NULL
on	NULL
IL-10	NULL
receptor	NULL
sequences	NULL
surrounding	NULL
Tyr®	NULL
``	NULL
*	NULL
,	NULL
Tyr*	NULL
``	NULL
``	NULL
,	NULL
and	NULL
Tyr*	NULL
``	NULL
``	NULL
(	NULL
¥.e	NULL
.	NULL

peptides	NULL
based	NULL
on	NULL
residues	NULL
370-381	NULL
,	NULL
392-403	NULL
,	NULL
423-434	NULL
,	NULL
and	NULL
473-484	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

The	NULL
peptides	NULL
contained	NULL
either	NULL
tyrosine	NULL
or	NULL
phosphotyrosine	NULL
residues	NULL
.	NULL

Stat3	NULL
was	NULL
precipitated	NULL
by	NULL
phosphotyrosine-containing	NULL
peptides	NULL
encompassing	NULL
the	NULL
amino	NULL
acids	NULL
around	NULL
Tyr*	NULL
``	NULL
(	NULL
residues	NULL
4238-434	NULL
)	NULL
or	NULL
Tyr*	NULL
``	NULL
``	NULL
(	NULL
residues	NULL
473-484	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
upper	NULL
panel	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
interaction	NULL
was	NULL
confirmed	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
Stat3	NULL
was	NULL
not	NULL
precipitated	NULL
by	NULL
biotinylated	NULL
forms	NULL
of	NULL
:	NULL
(	NULL
@	NULL
)	NULL
nonphosphorylated	NULL
Tyr®	NULL
``	NULL
-	NULL
or	NULL
Tyr*	NULL
``	NULL
``	NULL
-containing	NULL
peptides	NULL
(	NULL
upper	NULL
panel	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
,	NULL
respectively	NULL
)	NULL
;	NULL
(	NULL
b	NULL
)	NULL
phosphorylated	NULL
Tyr®'*-	NULL
or	NULL
Tyr®-containing	NULL
peptides	NULL
(	NULL
upper	NULL
panel	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
,	NULL
respectively	NULL
)	NULL
;	NULL
or	NULL
(	NULL
c	NULL
)	NULL
the	NULL
Statl	NULL
binding	NULL
phosphopeptide	NULL
derived	NULL
from	NULL
the	NULL
human	NULL
IFNy	NULL
receptor	NULL
a	NULL
chain	NULL
(	NULL
residues	NULL
436-447	NULL
in	NULL
the	NULL
intracellular	NULL
domain	NULL
)	NULL
(	NULL
upper	NULL
panel	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
none	NULL
of	NULL
the	NULL
IL-10	NULL
receptor-derived	NULL
peptides	NULL
were	NULL
able	NULL
to	NULL
coprecipitate	NULL
Statl	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lower	NULL
panel	NULL
,	NULL
lanes	NULL
1-6	NULL
)	NULL
,	NULL
although	NULL
Statl	NULL
could	NULL
be	NULL
precipitated	NULL
by	NULL
the	NULL
IFNy	NULL
receptor	NULL
phosphopeptide	NULL
(	NULL
Lower	NULL
panel	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

These	NULL
results	NULL
thus	NULL
showed	NULL
that	NULL
Stat3	NULL
but	NULL
not	NULL
Statl	NULL
has	NULL
the	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
intracellular	NULL
domain	NULL
sequences	NULL
of	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Stat3	NULL
Recruitment	NULL
by	NULL
the	NULL
IL-10	NULL
Receptor	NULL
M	NULL
,	NULL
(	NULL
kDa	NULL
)	NULL
Stat3	NULL
87	NULL
-	NULL
e	NULL
*~	NULL
M	NULL
,	NULL
(	NULL
kDa	NULL
)	NULL
Stati	NULL
87	NULL
-	NULL
ee	NULL
``	NULL
Peptide	NULL
containing	NULL
374	NULL
396	NULL
427	NULL
477	NULL
427	NULL
477,440	NULL
Tyrosine	NULL
residue	NULL
#	NULL
IL-10R	NULL
IFNyR	NULL
Phosphorylated	NULL
Tyrosine	NULL
+	NULL
+	NULL
+	NULL
+	NULL
-	NULL
-	NULL
+	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Coprecipitation	NULL
of	NULL
Stat3	NULL
with	NULL
biotinylated	NULL
tyrosine	NULL
phosphorylated	NULL
IL-10	NULL
receptor	NULL
peptides	NULL
containing	NULL
Tyr**	NULL
``	NULL
or	NULL
Tyr*	NULL
'	NULL
``	NULL
.	NULL

BaMR	NULL
cell	NULL
homogenates	NULL
were	NULL
incubated	NULL
with	NULL
biotinylated	NULL
12-amino	NULL
acid	NULL
peptides	NULL
that	NULL
were	NULL
based	NULL
on	NULL
the	NULL
murine	NULL
IL-10	NULL
receptor	NULL
sequence	NULL
surrounding	NULL
the	NULL
four	NULL
intracellular	NULL
domain	NULL
tyrosine	NULL
residues	NULL
at	NULL
positions	NULL
374	NULL
,	NULL
396	NULL
,	NULL
427	NULL
,	NULL
and	NULL
477	NULL
or	NULL
a	NULL
12-amino	NULL
acid	NULL
phosphopeptide	NULL
containing	NULL
the	NULL
Stat1	NULL
binding	NULL
site	NULL
derived	NULL
from	NULL
the	NULL
human	NULL
IFNy	NULL
receptor	NULL
a	NULL
chain	NULL
intracellular	NULL
domain	NULL
(	NULL
440	NULL
)	NULL
.	NULL

Biotinylated	NULL
peptides	NULL
were	NULL
precipitated	NULL
from	NULL
the	NULL
incubation	NULL
mixture	NULL
using	NULL
streptavidin-Sepharose	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
analyses	NULL
that	NULL
employed	NULL
antisera	NULL
specific	NULL
for	NULL
either	NULL
Stat8	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
or	NULL
Statl	NULL
(	NULL
Lower	NULL
panel	NULL
)	NULL
.	NULL

the	NULL
IL-10	NULL
receptor	NULL
containing	NULL
phosphorylated	NULL
forms	NULL
of	NULL
residues	NULL
Tyr*	NULL
``	NULL
or	NULL
Tyr4	NULL
?	NULL

``	NULL
,	NULL
IL-10	NULL
Receptor	NULL
Peptides	NULL
Containing	NULL
Phosphorylated	NULL
Tyr®	NULL
``	NULL
``	NULL
or	NULL
Tyr®	NULL
``	NULL
``	NULL
Block	NULL
Ligand-dependent	NULL
Stat3	NULL
Activation-If	NULL
Stat3	NULL
binds	NULL
to	NULL
phosphorylated	NULL
Tyr*	NULL
``	NULL
or	NULL
Tyr*	NULL
``	NULL
``	NULL
containing	NULL
IL-10	NULL
receptor	NULL
sequences	NULL
under	NULL
physiologic	NULL
conditions	NULL
,	NULL
then	NULL
phosphopeptides	NULL
containing	NULL
these	NULL
residues	NULL
should	NULL
inhibit	NULL
the	NULL
ligand-dependent	NULL
activation	NULL
of	NULL
Stat3	NULL
.	NULL

This	NULL
possibility	NULL
was	NULL
tested	NULL
in	NULL
a	NULL
cell-free	NULL
Stat3	NULL
activation	NULL
assay	NULL
in	NULL
which	NULL
cell	NULL
homogenates	NULL
were	NULL
pretreated	NULL
with	NULL
IL-10	NULL
receptor	NULL
peptides	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
purified	NULL
IL-10	NULL
.	NULL

Stat	NULL
activation	NULL
was	NULL
assessed	NULL
by	NULL
immuno-precipitation	NULL
and	NULL
phosphotyrosine-specific	NULL
Western	NULL
blot	NULL
analyses	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
top	NULL
panel	NULL
)	NULL
.	NULL

As	NULL
controls	NULL
for	NULL
protein	NULL
loading	NULL
,	NULL
phosphotyrosine	NULL
blots	NULL
were	NULL
stripped	NULL
and	NULL
reprobed	NULL
for	NULL
Stat3	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
bottom	NULL
panel	NULL
)	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
ligand	NULL
,	NULL
little	NULL
or	NULL
no	NULL
activated	NULL
phosphorylated	NULL
Stat3	NULL
was	NULL
observed	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
IL-10	NULL
to	NULL
the	NULL
homogenates	NULL
resulted	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
tyrosine-phosphorylated	NULL
Stat3	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
.	NULL

Pretreatment	NULL
of	NULL
BaMR	NULL
homogenates	NULL
with	NULL
phosphopeptides	NULL
containing	NULL
Tyr®'*	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
Tyr®	NULL
``	NULL
``	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
IL-10-induced	NULL
phosphorylation	NULL
of	NULL
Stat	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
preincubation	NULL
of	NULL
the	NULL
homogenates	NULL
with	NULL
the	NULL
phosphorylated	NULL
Tyr*	NULL
``	NULL
-containing	NULL
peptide	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
completely	NULL
inhibited	NULL
ligand-induced	NULL
Stat3	NULL
phosphorylation	NULL
.	NULL

The	NULL
phosphorylated	NULL
Tyr*	NULL
``	NULL
``	NULL
peptide	NULL
(	NULL
Zane	NULL
6	NULL
)	NULL
also	NULL
significantly	NULL
inhibited	NULL
ligand-dependent	NULL
phosphorylation	NULL
of	NULL
Stat3	NULL
.	NULL

Peptides	NULL
containing	NULL
nonphosphorylated	NULL
tyrosine	NULL
at	NULL
positions	NULL
427	NULL
(	NULL
Lane	NULL
7	NULL
)	NULL
or	NULL
477	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
failed	NULL
to	NULL
inhibit	NULL
IL-10-induced	NULL
Stat3	NULL
phosphorylation	NULL
.	NULL

Dose-response	NULL
inhibition	NULL
experiments	NULL
were	NULL
performed	NULL
to	NULL
further	NULL
investigate	NULL
the	NULL
apparent	NULL
potency	NULL
differences	NULL
observed	NULL
between	NULL
the	NULL
Tyr*	NULL
``	NULL
-	NULL
and	NULL
Tyr*	NULL
``	NULL
``	NULL
-containing	NULL
phosphopeptides	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

In	NULL
this	NULL
experiment	NULL
,	NULL
both	NULL
peptides	NULL
were	NULL
able	NULL
to	NULL
completely	NULL
inhibit	NULL
IL-10-induced	NULL
Stat3	NULL
phosphorylation	NULL
at	NULL
concentrations	NULL
of	NULL
100	NULL
and	NULL
20	NULL
uM	NULL
(	NULL
upper	NULL
panel	NULL
,	NULL
lanes	NULL
4	NULL
,	NULL
5	NULL
,	NULL
9	NULL
,	NULL
and	NULL
10	NULL
)	NULL
,	NULL
but	NULL
only	NULL
the	NULL
phosphorylated	NULL
Tyr*	NULL
``	NULL
peptide	NULL
was	NULL
capable	NULL
of	NULL
inhibiting	NULL
at	NULL
4	NULL
uM	NULL
(	NULL
compare	NULL
lanes	NULL
6	NULL
and	NULL
11	NULL
)	NULL
.	NULL

DISCUSSION	NULL
The	NULL
activation	NULL
of	NULL
STAT	NULL
proteins	NULL
by	NULL
interferons	NULL
as	NULL
well	NULL
as	NULL
other	NULL
cytokines	NULL
and	NULL
growth	NULL
factors	NULL
is	NULL
now	NULL
known	NULL
to	NULL
link	NULL
ligand-receptor	NULL
interaction	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
to	NULL
specific	NULL
gene	NULL
activa-	NULL
27959	NULL
M	NULL
,	NULL
(	NULL
kDa	NULL
)	NULL
IP	NULL
:	NULL
Stat3	NULL
Blot	NULL
:	NULL
P-TYR	NULL
116	NULL
87	NULL
-	NULL
Wi	NULL
cant	NULL
aaat	NULL
=s	NULL
M	NULL
,	NULL
(	NULL
kDa	NULL
)	NULL
IP	NULL
:	NULL
Stat3	NULL
Blot	NULL
:	NULL
Stat3	NULL
116	NULL
87	NULL
«	NULL
wo	NULL
«	NULL
i	NULL
%	NULL
un	NULL
«	NULL
n	NULL
on	NULL
on	NULL
-o	NULL
ats	NULL
poo	NULL
.	NULL

gous	NULL
ques	NULL
coos	NULL
Alim	NULL
Ai	NULL
A	NULL
IL-10	NULL
;	NULL
L0	NULL
#	NULL
#	NULL
0	NULL
4	NULL
#	NULL
0	NULL
4	NULL
+	NULL
+	NULL
#	NULL
w	NULL
-	NULL
@	NULL
Fr	NULL
har	NULL
J	NULL
B	NULL
Peptide	NULL
:	NULL
-	NULL
-	NULL
Os	NULL
$	NULL
N4	NULL
§	NULL
3	NULL
©	NULL
©	NULL
©	NULL
©	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

IL-10	NULL
receptor	NULL
peptides	NULL
containing	NULL
Tyr*	NULL
``	NULL
or	NULL
Tyr	NULL
``	NULL
inhibit	NULL
ligand-dependent	NULL
Stats	NULL
phosphorylation	NULL
.	NULL

BaMR	NULL
homogenates	NULL
from	NULL
10°	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
either	NULL
buffer	NULL
(	NULL
Janes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
the	NULL
following	NULL
IL-10	NULL
receptor	NULL
peptides	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
100	NULL
uM	NULL
:	NULL
phosphorylated	NULL
370-381	NULL
peptide	NULL
(	NULL
374-P	NULL
)	NULL
,	NULL
phosphorylated	NULL
392-403	NULL
peptide	NULL
(	NULL
396-P	NULL
)	NULL
,	NULL
phosphorylated	NULL
428-484	NULL
peptide	NULL
(	NULL
427-P	NULL
)	NULL
,	NULL
phosphorylated	NULL
473-484	NULL
peptide	NULL
(	NULL
477-P	NULL
)	NULL
,	NULL
or	NULL
the	NULL
nonphosphorylated	NULL
control	NULL
peptides	NULL
428-434	NULL
(	NULL
427	NULL
)	NULL
and	NULL
473-484	NULL
(	NULL
477	NULL
)	NULL
.	NULL

Incubation	NULL
was	NULL
performed	NULL
for	NULL
45	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
and	NULL
lysates	NULL
were	NULL
subsequently	NULL
stimulated	NULL
with	NULL
buffer	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
or	NULL
1	NULL
ug/ml	NULL
recombinant	NULL
murine	NULL
IL-10	NULL
for	NULL
15	NULL
min	NULL
at	NULL
87	NULL
°C	NULL
(	NULL
Zanes	NULL
2-8	NULL
)	NULL
.	NULL

After	NULL
stimulation	NULL
,	NULL
homogenates	NULL
were	NULL
solubilized	NULL
and	NULL
cleared	NULL
by	NULL
centrif-ugation	NULL
.	NULL

Stat3	NULL
was	NULL
precipitated	NULL
using	NULL
specific	NULL
immune	NULL
rabbit	NULL
serum	NULL
and	NULL
protein	NULL
A-Sepharose	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
and	NULL
phosphotyrosine-specific	NULL
Western	NULL
blotting	NULL
using	NULL
the	NULL
RC-20	NULL
mAb	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Subsequently	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
stripped	NULL
and	NULL
blotted	NULL
for	NULL
Stat8	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

M	NULL
;	NULL
(	NULL
kDa	NULL
)	NULL
IP	NULL
:	NULL
Statd	NULL
Blot	NULL
:	NULL
P-TYR	NULL
-	NULL
139-B6-	NULL
r	NULL
wam	NULL
meme	NULL
|	NULL
Gus	NULL
)	NULL
wih	NULL
With	NULL
IL410	NULL
;	NULL
_	NULL
+	NULL
+	NULL
+	NULL
#	NULL
#	NULL
4	NULL
&	NULL
0	NULL
$	NULL
0	NULL
#	NULL
+	NULL
#	NULL
%	NULL
Peptide	NULL
:	NULL
-	NULL
-	NULL
100	NULL
100	NULL
20	NULL
4	NULL
0.8	NULL
100	NULL
100	NULL
20	NULL
4	NULL
0.8	NULL
(	NULL
PM	NULL
)	NULL
L_L_______LUL__	NULL
I	NULL
427	NULL
42-	NULL
@	NULL
477	NULL
ar-	NULL
@	NULL
M	NULL
,	NULL
(	NULL
kDa	NULL
)	NULL
IP	NULL
:	NULL
Stat3	NULL
86	NULL
ma	NULL
,	NULL
Blot	NULL
:	NULL
Stat3	NULL
-	NULL
:	NULL
que	NULL
mames	NULL
tate	NULL
tut	NULL
tut	NULL
task	NULL
tant	NULL
+-	NULL
5115	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Dose-dependent	NULL
inhibition	NULL
of	NULL
Stat3	NULL
by	NULL
phosphorylated	NULL
IL-10	NULL
receptor	NULL
peptides	NULL
containing	NULL
Tyr**	NULL
``	NULL
or	NULL
Tyr*	NULL
'	NULL
``	NULL
.	NULL

BaMR	NULL
homogenates	NULL
were	NULL
incubated	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
with	NULL
:	NULL
no	NULL
peptide	NULL
(	NULL
Zanes	NULL
I	NULL
and	NULL
2	NULL
)	NULL
,	NULL
100	NULL
uM	NULL
nonphosphorylated	NULL
423-434	NULL
peptide	NULL
(	NULL
427	NULL
)	NULL
,	NULL
phosphorylated	NULL
423-434	NULL
peptide	NULL
in	NULL
decreasing	NULL
micromolar	NULL
concentrations	NULL
as	NULL
indicated	NULL
(	NULL
427-P	NULL
)	NULL
,	NULL
100	NULL
uM	NULL
nonphosphorylated	NULL
473-483	NULL
peptide	NULL
(	NULL
477	NULL
)	NULL
,	NULL
or	NULL
phosphorylated	NULL
473-483	NULL
peptide	NULL
in	NULL
decreasing	NULL
micromolar	NULL
concentrations	NULL
as	NULL
indicated	NULL
(	NULL
477-P	NULL
)	NULL
.	NULL

Reaction	NULL
mixtures	NULL
were	NULL
incubated	NULL
for	NULL
45	NULL
min	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
either	NULL
buffer	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
or	NULL
1	NULL
ug/ml	NULL
recombinant	NULL
murine	NULL
IL-10	NULL
(	NULL
Zanes	NULL
2-12	NULL
)	NULL
and	NULL
Stat8	NULL
immunoprecipitated	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Precipitates	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
Western	NULL
blotting	NULL
using	NULL
the	NULL
phosphotyrosine-specific	NULL
mAb	NULL
RC-20	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Blots	NULL
were	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
Stat8-specific	NULL
antiserum	NULL
(	NULL
fower	NULL
panel	NULL
)	NULL
.	NULL

tion	NULL
in	NULL
the	NULL
nucleus	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
these	NULL
latent	NULL
intracellular	NULL
transcription	NULL
factors	NULL
is	NULL
needed	NULL
for	NULL
their	NULL
activation	NULL
and	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
of	NULL
stimulated	NULL
cells	NULL
(	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

Different	NULL
cytokines	NULL
can	NULL
stimulate	NULL
the	NULL
activation	NULL
of	NULL
different	NULL
STAT	NULL
proteins	NULL
in	NULL
differing	NULL
amounts	NULL
and	NULL
with	NULL
different	NULL
kinetics	NULL
.	NULL

This	NULL
leads	NULL
to	NULL
the	NULL
generation	NULL
of	NULL
distinct	NULL
patterns	NULL
of	NULL
homo-	NULL
or	NULL
heterodimeric	NULL
STAT	NULL
complexes	NULL
that	NULL
are	NULL
at	NULL
least	NULL
partly	NULL
responsible	NULL
for	NULL
inducing	NULL
the	NULL
specific	NULL
pattern	NULL
of	NULL
gene	NULL
transcripts	NULL
activated	NULL
by	NULL
each	NULL
particular	NULL
cytokine	NULL
.	NULL

Based	NULL
on	NULL
our	NULL
study	NULL
of	NULL
IFNy	NULL
receptor	NULL
signaling	NULL
,	NULL
we	NULL
recently	NULL
proposed	NULL
that	NULL
the	NULL
specific	NULL
recruitment	NULL
of	NULL
latent	NULL
STAT	NULL
proteins	NULL
by	NULL
distinct	NULL
cytokine	NULL
receptors	NULL
is	NULL
determined	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
individual	NULL
STAT	NULL
family	NULL
members	NULL
to	NULL
interact	NULL
with	NULL
distinct	NULL
phosphotyrosine-containing	NULL
sequences	NULL
within	NULL
the	NULL
intracellular	NULL
domain	NULL
of	NULL
the	NULL
receptor	NULL
(	NULL
24	NULL
)	NULL
.	NULL

This	NULL
concept	NULL
was	NULL
initially	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
the	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
27960	NULL
demonstrations	NULL
that	NULL
:	NULL
(	NULL
@	NULL
)	NULL
highly	NULL
purified	NULL
Statl	NULL
binds	NULL
to	NULL
its	NULL
highly	NULL
purified	NULL
phosphorylated	NULL
IFNy	NULL
receptor	NULL
docking	NULL
site	NULL
with	NULL
an	NULL
affinity	NULL
of	NULL
70-137	NULL
nx	NULL
(	NULL
16	NULL
,	NULL
25	NULL
)	NULL
;	NULL
and	NULL
(	NULL
b	NULL
)	NULL
certain	NULL
phosphotyrosine-containing	NULL
peptides	NULL
derived	NULL
from	NULL
the	NULL
IL-4	NULL
receptor	NULL
can	NULL
bind	NULL
to	NULL
highly	NULL
purified	NULL
latent	NULL
Stat6	NULL
(	NULL
Stat6	NULL
is	NULL
the	NULL
STAT	NULL
protein	NULL
utilized	NULL
in	NULL
IL-4	NULL
signaling	NULL
)	NULL
(	NULL
36	NULL
)	NULL
and	NULL
dissociate	NULL
a	NULL
preformed	NULL
pu-rified	NULL
,	NULL
activated	NULL
Stat6	NULL
homodimer	NULL
(	NULL
16	NULL
)	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
similar	NULL
experiments	NULL
have	NULL
been	NULL
performed	NULL
for	NULL
STAT	NULL
activation	NULL
by	NULL
certain	NULL
other	NULL
cytokine	NULL
receptors	NULL
including	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
IFN	NULL
@	NULL
/B	NULL
(	NULL
26	NULL
,	NULL
37-39	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
report	NULL
,	NULL
we	NULL
now	NULL
extend	NULL
this	NULL
concept	NULL
to	NULL
IL-10	NULL
receptor	NULL
signaling	NULL
.	NULL

As	NULL
shown	NULL
herein	NULL
,	NULL
IL-10	NULL
induces	NULL
the	NULL
activation	NULL
of	NULL
two	NULL
specific	NULL
STAT	NULL
family	NULL
members	NULL
in	NULL
all	NULL
IL-10	NULL
receptor-expressing	NULL
cells	NULL
tested	NULL
,	NULL
Statl	NULL
and	NULL
Stat3	NULL
.	NULL

Moreover	NULL
,	NULL
IL-10	NULL
activates	NULL
a	NULL
third	NULL
STAT	NULL
protein	NULL
(	NULL
Stat5	NULL
)	NULL
in	NULL
pro-B	NULL
cells	NULL
that	NULL
have	NULL
been	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
wild-type	NULL
murine	NULL
IL-10	NULL
receptor	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
Stat5	NULL
expression	NULL
in	NULL
BaMR	NULL
,	NULL
Raw264.7	NULL
,	NULL
and	NULL
PEC	NULL
cells	NULL
are	NULL
roughly	NULL
equivalent	NULL
;	NULL
therefore	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
IL-10	NULL
receptor	NULL
to	NULL
activate	NULL
Stat5	NULL
in	NULL
Ba/F3	NULL
cells	NULL
is	NULL
apparently	NULL
not	NULL
due	NULL
to	NULL
high	NULL
expression	NULL
levels	NULL
of	NULL
Stat5	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

The	NULL
utilization	NULL
of	NULL
Stat3	NULL
by	NULL
the	NULL
IL-10	NULL
receptor	NULL
was	NULL
found	NULL
to	NULL
be	NULL
the	NULL
result	NULL
of	NULL
the	NULL
interaction	NULL
of	NULL
Stat3	NULL
with	NULL
either	NULL
one	NULL
of	NULL
two	NULL
phosphotyrosine-containing	NULL
sequences	NULL
within	NULL
the	NULL
membrane	NULL
distal	NULL
portion	NULL
of	NULL
the	NULL
intracellular	NULL
domain	NULL
of	NULL
the	NULL
IL-10	NULL
receptor	NULL
.	NULL

The	NULL
sequences	NULL
encompassing	NULL
the	NULL
Stat3	NULL
binding	NULL
sites	NULL
on	NULL
the	NULL
IL-10	NULL
receptor	NULL
were	NULL
distinct	NULL
from	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
Stat1l	NULL
binding	NULL
site	NULL
defined	NULL
previously	NULL
on	NULL
the	NULL
IFNy	NULL
receptor	NULL
and	NULL
did	NULL
not	NULL
react	NULL
with	NULL
Stat1l	NULL
.	NULL

Thus	NULL
,	NULL
our	NULL
results	NULL
support	NULL
the	NULL
concept	NULL
that	NULL
at	NULL
least	NULL
some	NULL
cytokine	NULL
receptors	NULL
mediate	NULL
their	NULL
specific	NULL
biologic	NULL
responses	NULL
through	NULL
a	NULL
direct	NULL
interaction	NULL
of	NULL
the	NULL
intracellular	NULL
domain	NULL
of	NULL
the	NULL
receptor	NULL
with	NULL
specific	NULL
STAT	NULL
family	NULL
members	NULL
and	NULL
that	NULL
the	NULL
specific	NULL
array	NULL
of	NULL
STAT	NULL
proteins	NULL
utilized	NULL
by	NULL
distinct	NULL
cytokine	NULL
receptors	NULL
is	NULL
determined	NULL
by	NULL
binding	NULL
site	NULL
specificity	NULL
of	NULL
specific	NULL
STAT	NULL
proteins	NULL
.	NULL

The	NULL
mechanism	NULL
of	NULL
recruitment	NULL
of	NULL
Statl	NULL
and	NULL
Stat5	NULL
to	NULL
the	NULL
ligated	NULL
IL-10	NULL
receptor	NULL
is	NULL
left	NULL
unanswered	NULL
by	NULL
these	NULL
binding	NULL
experi-ments	NULL
.	NULL

However	NULL
,	NULL
this	NULL
report	NULL
documents	NULL
a	NULL
relatively	NULL
unique	NULL
feature	NULL
of	NULL
the	NULL
IL-10	NULL
receptor	NULL
in	NULL
its	NULL
ability	NULL
to	NULL
recruit	NULL
different	NULL
STAT	NULL
proteins	NULL
via	NULL
distinct	NULL
docking	NULL
sites	NULL
.	NULL

The	NULL
functionally	NULL
important	NULL
regions	NULL
of	NULL
the	NULL
intracellular	NULL
domain	NULL
of	NULL
the	NULL
murine	NULL
IL-10	NULL
receptor	NULL
were	NULL
identified	NULL
using	NULL
deletion	NULL
and	NULL
substitution	NULL
mutagenesis	NULL
approaches	NULL
.	NULL

These	NULL
experiments	NULL
were	NULL
possible	NULL
because	NULL
expression	NULL
of	NULL
wild-type	NULL
murine	NULL
IL-10	NULL
receptors	NULL
in	NULL
Ba/F3	NULL
cells	NULL
leads	NULL
to	NULL
the	NULL
generation	NULL
of	NULL
a	NULL
functionally	NULL
active	NULL
receptor	NULL
that	NULL
signals	NULL
for	NULL
IL-10-dependent	NULL
proliferative	NULL
responses	NULL
(	NULL
1	NULL
,	NULL
10	NULL
)	NULL
.	NULL

This	NULL
approach	NULL
showed	NULL
that	NULL
two	NULL
tyrosine	NULL
residues	NULL
at	NULL
positions	NULL
427	NULL
and	NULL
477	NULL
could	NULL
each	NULL
function	NULL
in	NULL
the	NULL
IL-10	NULL
signal	NULL
transduction	NULL
process	NULL
.	NULL

Although	NULL
individual	NULL
substitution	NULL
of	NULL
either	NULL
Tyr*	NULL
``	NULL
or	NULL
Tyr*	NULL
'	NULL
``	NULL
with	NULL
phenylalanine	NULL
did	NULL
not	NULL
ablate	NULL
IL-10-dependent	NULL
proliferative	NULL
responses	NULL
,	NULL
substitution	NULL
of	NULL
both	NULL
residues	NULL
led	NULL
to	NULL
the	NULL
generation	NULL
of	NULL
a	NULL
functionally	NULL
inactive	NULL
receptor	NULL
.	NULL

Similar	NULL
effects	NULL
were	NULL
observed	NULL
using	NULL
an	NULL
EMSA	NULL
that	NULL
monitored	NULL
IL-10-dependent	NULL
STAT	NULL
activation	NULL
.	NULL

Moreover	NULL
,	NULL
cells	NULL
bearing	NULL
the	NULL
IL-10	NULL
receptor	NULL
deletion	NULL
mutant	NULL
A402-559	NULL
activated	NULL
Stat1	NULL
and	NULL
Stat5	NULL
upon	NULL
ligand	NULL
binding	NULL
,	NULL
whereas	NULL
Stat3	NULL
activation	NULL
was	NULL
completely	NULL
ablated	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
biochemistry	NULL
of	NULL
Stat3	NULL
activation	NULL
is	NULL
placed	NULL
in	NULL
contrast	NULL
to	NULL
that	NULL
of	NULL
Statl	NULL
or	NULL
Stat5	NULL
.	NULL

Using	NULL
phosphopeptides	NULL
in	NULL
a	NULL
manner	NULL
similar	NULL
to	NULL
that	NULL
used	NULL
to	NULL
identify	NULL
the	NULL
Statl	NULL
binding	NULL
site	NULL
on	NULL
the	NULL
IFNy	NULL
receptor	NULL
(	NULL
24	NULL
)	NULL
,	NULL
the	NULL
interaction	NULL
of	NULL
Stat3	NULL
was	NULL
demonstrated	NULL
with	NULL
either	NULL
of	NULL
the	NULL
two	NULL
sequences	NULL
derived	NULL
from	NULL
a	NULL
membrane	NULL
distal	NULL
portion	NULL
of	NULL
the	NULL
intracellular	NULL
domain	NULL
of	NULL
the	NULL
IL-10	NULL
receptor	NULL
encompassing	NULL
phosphorylated	NULL
forms	NULL
of	NULL
Tyr*	NULL
``	NULL
and	NULL
Tyr*	NULL
``	NULL
``	NULL
.	NULL

The	NULL
biological	NULL
relevance	NULL
of	NULL
this	NULL
interaction	NULL
was	NULL
demonstrated	NULL
by	NULL
showing	NULL
that	NULL
phosphotyrosine-containing	NULL
peptides	NULL
corresponding	NULL
to	NULL
the	NULL
amino	NULL
acids	NULL
423-434	NULL
and	NULL
473-484	NULL
of	NULL
the	NULL
IL-10	NULL
receptor	NULL
inhibited	NULL
IL-10-dependent	NULL
Stat3	NULL
activation	NULL
,	NULL
whereas	NULL
peptides	NULL
encompassing	NULL
the	NULL
Stat3	NULL
Recruitment	NULL
by	NULL
the	NULL
IL-10	NULL
Receptor	NULL
other	NULL
two	NULL
potential	NULL
phosphotyrosine-containing	NULL
receptor	NULL
sequences	NULL
did	NULL
not	NULL
.	NULL

The	NULL
apparent	NULL
overlapping	NULL
actions	NULL
of	NULL
Tyr*	NULL
``	NULL
and	NULL
Tyr*	NULL
``	NULL
``	NULL
in	NULL
the	NULL
IL-10	NULL
receptor	NULL
are	NULL
in	NULL
contrast	NULL
with	NULL
the	NULL
single	NULL
functionally	NULL
important	NULL
tyrosine	NULL
residue	NULL
in	NULL
the	NULL
intracellular	NULL
domain	NULL
of	NULL
the	NULL
IFNy	NULL
receptor	NULL
a	NULL
chain	NULL
(	NULL
24	NULL
)	NULL
.	NULL

In	NULL
the	NULL
latter	NULL
case	NULL
,	NULL
ligand-induced	NULL
IFNy	NULL
receptor	NULL
a	NULL
chain	NULL
dimerization	NULL
is	NULL
thought	NULL
to	NULL
bring	NULL
into	NULL
close	NULL
proximity	NULL
two	NULL
receptor-bound	NULL
Statl	NULL
molecules	NULL
that	NULL
results	NULL
in	NULL
the	NULL
efficient	NULL
generation	NULL
of	NULL
an	NULL
activated	NULL
phosphorylated	NULL
Statl	NULL
homodimer	NULL
(	NULL
24	NULL
,	NULL
34	NULL
,	NULL
40-42	NULL
)	NULL
.	NULL

This	NULL
concept	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
murine	NULL
IFNy	NULL
receptor	NULL
a	NULL
chains	NULL
either	NULL
containing	NULL
a	NULL
point	NULL
mutation	NULL
at	NULL
the	NULL
functionally	NULL
critical	NULL
Tyr*	NULL
``	NULL
position	NULL
or	NULL
lacking	NULL
all	NULL
but	NULL
three	NULL
intracellular	NULL
domain	NULL
amino	NULL
acids	NULL
act	NULL
as	NULL
dominant-negative	NULL
mutants	NULL
(	NULL
43	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
we	NULL
have	NULL
not	NULL
been	NULL
able	NULL
to	NULL
detect	NULL
a	NULL
dominant-negative	NULL
effect	NULL
by	NULL
a	NULL
cytoplasmically	NULL
truncated	NULL
form	NULL
of	NULL
the	NULL
IL-10	NULL
receptor	NULL
.	NULL
``	NULL

This	NULL
result	NULL
suggests	NULL
that	NULL
either	NULL
IL-10	NULL
receptor	NULL
dimerization	NULL
may	NULL
not	NULL
be	NULL
important	NULL
in	NULL
the	NULL
signaling	NULL
process	NULL
or	NULL
that	NULL
the	NULL
two	NULL
redundant	NULL
tyrosine	NULL
residues	NULL
within	NULL
the	NULL
native	NULL
IL-10	NULL
receptor	NULL
intracellular	NULL
domain	NULL
provides	NULL
a	NULL
backup	NULL
mechanism	NULL
that	NULL
insures	NULL
effective	NULL
Stat3	NULL
dimerization	NULL
.	NULL

The	NULL
intracellular	NULL
domains	NULL
of	NULL
the	NULL
human	NULL
and	NULL
murine	NULL
IL-10	NULL
receptor	NULL
proteins	NULL
are	NULL
only	NULL
60	NULL
%	NULL
identical	NULL
at	NULL
the	NULL
amino	NULL
acid	NULL
level	NULL
(	NULL
1	NULL
,	NULL
10	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
human	NULL
protein	NULL
contains	NULL
only	NULL
two	NULL
conserved	NULL
intracellular	NULL
domain	NULL
tyrosine	NULL
residues	NULL
(	NULL
Tyr**	NULL
``	NULL
and	NULL
Tyr*	NULL
``	NULL
``	NULL
)	NULL
that	NULL
correspond	NULL
to	NULL
the	NULL
two	NULL
functionally	NULL
important	NULL
tyrosines	NULL
we	NULL
identified	NULL
in	NULL
the	NULL
intracellular	NULL
domain	NULL
of	NULL
the	NULL
murine	NULL
IL-10	NULL
receptor	NULL
(	NULL
i.e	NULL
.	NULL

Tyr*	NULL
``	NULL
and	NULL
Tyr*	NULL
``	NULL
``	NULL
)	NULL
.	NULL

Perhaps	NULL
of	NULL
importance	NULL
,	NULL
the	NULL
sequences	NULL
surrounding	NULL
each	NULL
of	NULL
the	NULL
two	NULL
conserved	NULL
tyrosine	NULL
residues	NULL
are	NULL
conserved	NULL
.	NULL

Specifically	NULL
,	NULL
the	NULL
murine	NULL
and	NULL
human	NULL
sequences	NULL
containing	NULL
the	NULL
equivalent	NULL
of	NULL
the	NULL
murine	NULL
Tyr*	NULL
``	NULL
residue	NULL
are	NULL
FQGYQKQTR	NULL
and	NULL
FQGYLRQTR	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
the	NULL
murine	NULL
and	NULL
human	NULL
sequences	NULL
containing	NULL
the	NULL
murine	NULL
Tyr*	NULL
``	NULL
``	NULL
equivalent	NULL
are	NULL
AAGYLKQES	NULL
and	NULL
AKGYLKQD	NULL
,	NULL
respec-tively	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
functional	NULL
importance	NULL
of	NULL
these	NULL
two	NULL
intracellular	NULL
domain	NULL
regions	NULL
is	NULL
also	NULL
suggested	NULL
by	NULL
the	NULL
conservation	NULL
of	NULL
sequence	NULL
around	NULL
the	NULL
two	NULL
membrane	NULL
distal	NULL
tyrosine	NULL
residues	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
two	NULL
sets	NULL
of	NULL
human	NULL
and	NULL
murine	NULL
intracellular	NULL
domain	NULL
sequences	NULL
share	NULL
remarkable	NULL
sequence	NULL
similarities	NULL
to	NULL
one	NULL
another	NULL
,	NULL
especially	NULL
at	NULL
positions	NULL
-1	NULL
to	NULL
+4	NULL
relative	NULL
to	NULL
the	NULL
tyrosine	NULL
residue	NULL
.	NULL

The	NULL
consensus	NULL
sequence	NULL
appears	NULL
to	NULL
be	NULL
GYLKQHy	NULL
,	NULL
where	NULL
Hy	NULL
is	NULL
an	NULL
amino	NULL
acid	NULL
with	NULL
a	NULL
terminal	NULL
hydrophilic	NULL
group	NULL
.	NULL

If	NULL
this	NULL
sequence	NULL
represents	NULL
an	NULL
authentic	NULL
Stat3	NULL
binding	NULL
site	NULL
(	NULL
which	NULL
becomes	NULL
activated	NULL
upon	NULL
phosphorylation	NULL
of	NULL
the	NULL
tyrosine	NULL
residue	NULL
)	NULL
,	NULL
it	NULL
would	NULL
be	NULL
expected	NULL
to	NULL
occur	NULL
in	NULL
the	NULL
polypeptides	NULL
of	NULL
receptors	NULL
for	NULL
other	NULL
cytokines	NULL
that	NULL
utilize	NULL
Stat3	NULL
for	NULL
signaling	NULL
.	NULL

It	NULL
is	NULL
,	NULL
therefore	NULL
,	NULL
of	NULL
interest	NULL
that	NULL
four	NULL
similar	NULL
sequences	NULL
occur	NULL
within	NULL
the	NULL
intracellular	NULL
domain	NULL
of	NULL
gp130	NULL
,	NULL
which	NULL
is	NULL
known	NULL
to	NULL
induce	NULL
Stat3	NULL
activation	NULL
.	NULL

These	NULL
include	NULL
the	NULL
GYRHQV	NULL
,	NULL
QY-FKQN	NULL
,	NULL
SYLPQT	NULL
,	NULL
and	NULL
GYMPQ	NULL
sequences	NULL
found	NULL
at	NULL
various	NULL
positions	NULL
in	NULL
the	NULL
intracellular	NULL
domains	NULL
of	NULL
both	NULL
murine	NULL
and	NULL
human	NULL
gp130	NULL
.	NULL

The	NULL
latter	NULL
two	NULL
sequences	NULL
have	NULL
recently	NULL
been	NULL
implicated	NULL
in	NULL
Stat3	NULL
binding	NULL
to	NULL
gp130	NULL
by	NULL
transplanting	NULL
them	NULL
into	NULL
the	NULL
eryth-ropoietin	NULL
receptor	NULL
intracellular	NULL
domain	NULL
,	NULL
thereby	NULL
conferring	NULL
on	NULL
that	NULL
receptor	NULL
the	NULL
ability	NULL
to	NULL
activate	NULL
Stat3	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
putative	NULL
Stat3	NULL
binding	NULL
motif	NULL
is	NULL
distinct	NULL
from	NULL
the	NULL
Statl	NULL
binding	NULL
site	NULL
that	NULL
we	NULL
identified	NULL
previously	NULL
within	NULL
the	NULL
IFNy	NULL
receptor	NULL
a	NULL
chain	NULL
intracellular	NULL
domain	NULL
(	NULL
GYDKPH	NULL
)	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
IFNy	NULL
receptor	NULL
structure-function	NULL
analyses	NULL
and	NULL
Statl	NULL
binding	NULL
assays	NULL
,	NULL
we	NULL
know	NULL
that	NULL
the	NULL
IFNy	NULL
receptor	NULL
residues	NULL
at	NULL
positions	NULL
+1	NULL
and	NULL
+4	NULL
relative	NULL
to	NULL
the	NULL
phosphotyrosine	NULL
are	NULL
critical	NULL
for	NULL
mediating	NULL
high	NULL
affinity	NULL
Statl	NULL
interaction	NULL
with	NULL
the	NULL
phosphorylated	NULL
IFNy	NULL
receptor	NULL
(	NULL
23-25	NULL
)	NULL
.	NULL

It	NULL
is	NULL
of	NULL
importance	NULL
that	NULL
the	NULL
IFNy	NULL
receptor	NULL
phosphopeptide	NULL
did	NULL
not	NULL
coprecipitate	NULL
Stat3	NULL
,	NULL
thus	NULL
con	NULL
*	NULL
R.	NULL
M.	NULL
Weber-Nordt	NULL
and	NULL
R.	NULL
D.	NULL
Schreiber	NULL
,	NULL
unpublished	NULL
observation	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Stat3	NULL
Recruitment	NULL
by	NULL
the	NULL
IL-10	NULL
Receptor	NULL
firming	NULL
that	NULL
the	NULL
Stat3	NULL
binding	NULL
site	NULL
is	NULL
distinct	NULL
from	NULL
that	NULL
of	NULL
Statl	NULL
.	NULL

We	NULL
have	NULL
not	NULL
yet	NULL
established	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
key	NULL
residues	NULL
within	NULL
the	NULL
motif	NULL
that	NULL
mediates	NULL
Stat3	NULL
attachment	NULL
,	NULL
nor	NULL
have	NULL
we	NULL
defined	NULL
whether	NULL
these	NULL
residues	NULL
will	NULL
be	NULL
in	NULL
the	NULL
same	NULL
+1	NULL
and	NULL
+4	NULL
orientation	NULL
relative	NULL
to	NULL
the	NULL
phosphotyrosine	NULL
as	NULL
was	NULL
observed	NULL
for	NULL
Stat1	NULL
.	NULL

These	NULL
experiments	NULL
are	NULL
currently	NULL
ongoing	NULL
in	NULL
the	NULL
laboratory	NULL
.	NULL

The	NULL
experiments	NULL
described	NULL
in	NULL
this	NULL
report	NULL
have	NULL
focused	NULL
entirely	NULL
on	NULL
the	NULL
importance	NULL
of	NULL
specific	NULL
tyrosine-containing	NULL
receptor	NULL
sequences	NULL
responsible	NULL
for	NULL
STAT	NULL
recruitment	NULL
.	NULL

An	NULL
important	NULL
issue	NULL
not	NULL
addressed	NULL
in	NULL
this	NULL
study	NULL
is	NULL
the	NULL
region	NULL
of	NULL
the	NULL
STAT	NULL
proteins	NULL
responsible	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
receptor	NULL
.	NULL

Since	NULL
Stat3	NULL
,	NULL
like	NULL
the	NULL
other	NULL
STAT	NULL
proteins	NULL
,	NULL
contains	NULL
an	NULL
SH2	NULL
domain	NULL
,	NULL
it	NULL
is	NULL
logical	NULL
that	NULL
these	NULL
regions	NULL
are	NULL
responsible	NULL
for	NULL
docking	NULL
to	NULL
the	NULL
phosphotyrosine-containing	NULL
sequence	NULL
in	NULL
the	NULL
activated	NULL
IL-10	NULL
receptor	NULL
.	NULL

This	NULL
idea	NULL
is	NULL
supported	NULL
by	NULL
two	NULL
recent	NULL
observations	NULL
derived	NULL
in	NULL
experiments	NULL
that	NULL
were	NULL
focused	NULL
on	NULL
defining	NULL
the	NULL
mechanism	NULL
of	NULL
IFN	NULL
signaling	NULL
.	NULL

1	NULL
)	NULL
Statl	NULL
containing	NULL
the	NULL
Stat2	NULL
SH2	NULL
domain	NULL
is	NULL
no	NULL
longer	NULL
activated	NULL
by	NULL
IFNy	NULL
and	NULL
Stat2	NULL
;	NULL
the	NULL
STAT	NULL
protein	NULL
activated	NULL
only	NULL
by	NULL
the	NULL
IFN	NULL
«	NULL
/B	NULL
receptor	NULL
and	NULL
not	NULL
the	NULL
IFNy	NULL
receptor	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
IFNy	NULL
if	NULL
it	NULL
contains	NULL
the	NULL
Statl	NULL
SH2	NULL
domain	NULL
(	NULL
27	NULL
)	NULL
.	NULL

2	NULL
)	NULL
Monoclonal	NULL
antibodies	NULL
specific	NULL
for	NULL
the	NULL
Statl	NULL
SH2	NULL
domain	NULL
block	NULL
binding	NULL
of	NULL
purified	NULL
latent	NULL
Statl	NULL
to	NULL
the	NULL
tyrosine-phosphorylated	NULL
IFNy	NULL
receptor	NULL
docking	NULL
site	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
SH2	NULL
domains	NULL
of	NULL
STAT	NULL
proteins	NULL
function	NULL
to	NULL
mediate	NULL
two	NULL
distinct	NULL
sets	NULL
of	NULL
protein-protein	NULL
interactions	NULL
during	NULL
the	NULL
activation	NULL
process	NULL
.	NULL

The	NULL
first	NULL
is	NULL
an	NULL
interaction	NULL
that	NULL
permits	NULL
specific	NULL
recruitment	NULL
of	NULL
the	NULL
latent	NULL
STAT	NULL
protein	NULL
to	NULL
the	NULL
activated	NULL
cytokine	NULL
receptor	NULL
.	NULL

The	NULL
second	NULL
is	NULL
the	NULL
interaction	NULL
that	NULL
occurs	NULL
between	NULL
tyrosine-phosphorylated	NULL
STAT	NULL
proteins	NULL
that	NULL
results	NULL
in	NULL
the	NULL
concomitant	NULL
release	NULL
of	NULL
these	NULL
proteins	NULL
from	NULL
the	NULL
receptor	NULL
and	NULL
their	NULL
dimerization	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
a	NULL
moiety	NULL
capable	NULL
of	NULL
translocating	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
activating	NULL
cytokine-inducible	NULL
genes	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
the	NULL
results	NULL
presented	NULL
herein	NULL
and	NULL
elsewhere	NULL
suggest	NULL
that	NULL
the	NULL
recruitment	NULL
of	NULL
specific	NULL
STAT	NULL
proteins	NULL
by	NULL
distinct	NULL
cytokine	NULL
receptors	NULL
is	NULL
a	NULL
function	NULL
that	NULL
is	NULL
predetermined	NULL
by	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
STAT	NULL
protein	NULL
for	NULL
a	NULL
particular	NULL
phosphotyrosine-containing	NULL
sequence	NULL
in	NULL
the	NULL
intracellular	NULL
domain	NULL
of	NULL
the	NULL
activated	NULL
receptor	NULL
.	NULL

Acknowledgment-We	NULL
are	NULL
grateful	NULL
to	NULL
Dr.	NULL
Brian	NULL
Drucker	NULL
for	NULL
providing	NULL
the	NULL
4G10	NULL
mAb	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Liu	NULL
,	NULL
Y.	NULL
,	NULL
Wei	NULL
,	NULL
S	NULL
.	NULL

H.-Y	NULL
.	NULL

,	NULL
Ho	NULL
,	NULL
A	NULL
.	NULL

S.-Y	NULL
.	NULL

,	NULL
de	NULL
Waal	NULL
Malefyt	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Moore	NULL
,	NULL
K.	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

152	NULL
,	NULL
1821-1829	NULL
2	NULL
.	NULL

Moore	NULL
,	NULL
K.	NULL
W.	NULL
,	NULL
O'Garra	NULL
,	NULL
A.	NULL
,	NULL
de	NULL
Waal	NULL
Malefyt	NULL
,	NULL
R.	NULL
,	NULL
Vieira	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Mosmann	NULL
,	NULL
T.	NULL
R.	NULL
(	NULL
19938	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

11	NULL
,	NULL
165-190	NULL
3	NULL
.	NULL

Moore	NULL
,	NULL
K.	NULL
W.	NULL
,	NULL
Vieira	NULL
,	NULL
P.	NULL
,	NULL
Fiorentino	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
Trounstine	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Khan	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
Mosmann	NULL
,	NULL
T.	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
248	NULL
,	NULL
1230-1234	NULL
4	NULL
.	NULL

Oswald	NULL
,	NULL
I.	NULL
P.	NULL
,	NULL
Wynn	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Sher	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
James	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1998	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
8676-8680	NULL
5	NULL
.	NULL

Rousset	NULL
,	NULL
F.	NULL
,	NULL
Garcia	NULL
,	NULL
E.	NULL
,	NULL
Defrance	NULL
,	NULL
T.	NULL
,	NULL
Peronne	NULL
,	NULL
C.	NULL
,	NULL
Vessio	NULL
,	NULL
N.	NULL
,	NULL
Hsu	NULL
,	NULL
D-H.	NULL
,	NULL
Kastelein	NULL
,	NULL
R.	NULL
,	NULL
Moore	NULL
,	NULL
K.	NULL
W.	NULL
,	NULL
and	NULL
Banchereau	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

27961	NULL
Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
1890-1893	NULL
6	NULL
.	NULL

Howard	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
O'Garra	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
13	NULL
,	NULL
198-200	NULL
19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22.	NULL
.	NULL

Farrar	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Campbell	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Schreiber	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30.	NULL
.	NULL

Ho	NULL
,	NULL
A	NULL
.	NULL

S.-Y	NULL
.	NULL

,	NULL
Wei	NULL
,	NULL
S	NULL
.	NULL

H.-Y	NULL
.	NULL

,	NULL
Mui	NULL
,	NULL
A.	NULL
L.-F.	NULL
,	NULL
Miyajima	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Moore	NULL
,	NULL
K.	NULL
W.	NULL
(	NULL
1995	NULL
)	NULL
32.	NULL
.	NULL

Horvath	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Wen	NULL
,	NULL
Z.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1995	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

9	NULL
,	NULL
984-994	NULL
34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43.	NULL
.	NULL

Mosmann	NULL
,	NULL
T.	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Inf	NULL
.	NULL

Arch	NULL
.	NULL

Allergy	NULL
Appl	NULL
.	NULL

Immunol	NULL
.	NULL

94	NULL
,	NULL
110-115	NULL
.	NULL

O'Garra	NULL
,	NULL
A.	NULL
O.	NULL
,	NULL
Stapleton	NULL
,	NULL
G.	NULL
,	NULL
Dhar	NULL
,	NULL
V.	NULL
,	NULL
Pearce	NULL
,	NULL
M.	NULL
,	NULL
Schumacher	NULL
,	NULL
J.	NULL
,	NULL
Rugo	NULL
,	NULL
H.	NULL
,	NULL
Barbis	NULL
,	NULL
D.	NULL
,	NULL
Stall	NULL
,	NULL
A.	NULL
,	NULL
Cupp	NULL
,	NULL
J.	NULL
,	NULL
Moore	NULL
,	NULL
K.	NULL
,	NULL
Vieira	NULL
,	NULL
P.	NULL
,	NULL
Mosmann	NULL
,	NULL
T.	NULL
,	NULL
Whitmore	NULL
,	NULL
A.	NULL
,	NULL
Arnold	NULL
,	NULL
L.	NULL
,	NULL
Haughton	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Howard	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Int	NULL
.	NULL

Immunol	NULL
.	NULL

2	NULL
,	NULL
821-831	NULL
.	NULL

Taga	NULL
,	NULL
K.	NULL
,	NULL
Mostowski	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Tosato	NULL
,	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
81	NULL
,	NULL
2964-2971	NULL
.	NULL

Ho	NULL
,	NULL
A.	NULL
S.	NULL
Y.	NULL
,	NULL
Liu	NULL
,	NULL
Y.	NULL
,	NULL
Khan	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Hsu	NULL
,	NULL
D-H.	NULL
,	NULL
Bazan	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
and	NULL
Moore	NULL
,	NULL
K.	NULL
W.	NULL
(	NULL
1998	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
11267-11271	NULL
.	NULL

Tan	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Indelicato	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Narula	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
Zavodny	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
Chou	NULL
,	NULL
C-C.	NULL
(	NULL
19938	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
21058-21059	NULL
.	NULL

Weber-Nordt	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Meraz	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Schreiber	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

153	NULL
,	NULL
8784-3744	NULL
.	NULL

Bazan	NULL
,	NULL
J.	NULL
F.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
6984-6938	NULL
.	NULL

Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
,	NULL
Kerr	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
and	NULL
Stark	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
264	NULL
,	NULL
1415-1421	NULL
.	NULL

Fu	NULL
,	NULL
X.-Y	NULL
.	NULL

,	NULL
and	NULL
Zhang	NULL
,	NULL
J.-J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Cell	NULL
74	NULL
,	NULL
1185-1145	NULL
.	NULL

Hou	NULL
,	NULL
J.	NULL
,	NULL
Schindler	NULL
,	NULL
U.	NULL
,	NULL
Henzel	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Ho	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
Brasseur	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
McKnight	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
265	NULL
,	NULL
1701-1706	NULL
.	NULL

Kotanides	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Reich	NULL
,	NULL
N.	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
1265-1267	NULL
.	NULL

Miyajima	NULL
,	NULL
A.	NULL
,	NULL
Kitamura	NULL
,	NULL
T.	NULL
,	NULL
Harada	NULL
,	NULL
N.	NULL
,	NULL
Yokota	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Arai	NULL
,	NULL
K.-I	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

10	NULL
,	NULL
295-331	NULL
Sadowski	NULL
,	NULL
H.	NULL
B.	NULL
,	NULL
Shuai	NULL
,	NULL
K.	NULL
,	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
Gilman	NULL
,	NULL
M.	NULL
Z	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
1739-1744	NULL
Shuai	NULL
,	NULL
K.	NULL
,	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
Prezioso	NULL
,	NULL
V.	NULL
R.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
258	NULL
,	NULL
1808-1812	NULL
Yamamoto	NULL
,	NULL
K.	NULL
,	NULL
Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Thierfelder	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
Kreider	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
Gilbert	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Jenkins	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
Copeland	NULL
,	NULL
N.	NULL
G.	NULL
,	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
,	NULL
and	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
4842-4849	NULL
Zhong	NULL
,	NULL
Z.	NULL
,	NULL
Wen	NULL
,	NULL
Z.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
264	NULL
,	NULL
95-98	NULL
Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
11706-11710	NULL
Greenlund	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Farrar	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Viviano	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
and	NULL
Schreiber	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
1591-1600	NULL
Greenlund	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Morales	NULL
,	NULL
M.	NULL
O.	NULL
,	NULL
Viviano	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
Yan	NULL
,	NULL
H.	NULL
,	NULL
Krolewski	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Schreiber	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Immunity	NULL
2	NULL
,	NULL
677-687	NULL
Stahl	NULL
,	NULL
N.	NULL
,	NULL
Farrugglella	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Boulton	NULL
,	NULL
T.	NULL
G.	NULL
,	NULL
Zhong	NULL
,	NULL
Z.	NULL
,	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
.	NULL

Yancopoulos	NULL
,	NULL
G.	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
267	NULL
,	NULL
1849-1353	NULL
Heim	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Kerr	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
Stark	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
267	NULL
,	NULL
1347-1349	NULL
Larner	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
David	NULL
,	NULL
M.	NULL
,	NULL
Feldman	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
Igarashi	NULL
,	NULL
K.-L.	NULL
,	NULL
Hackett	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
Webb	NULL
,	NULL
D.	NULL
S.	NULL
A.	NULL
,	NULL
Sweitzer	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Petricoin	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
III	NULL
,	NULL
and	NULL
Finbloom	NULL
,	NULL
D.	NULL
S.	NULL
(	NULL
1998	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
1730-1733	NULL
Lehmann	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Seegert	NULL
,	NULL
D.	NULL
,	NULL
Strehlow	NULL
,	NULL
I.	NULL
,	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
Lohmann-Matthes	NULL
,	NULL
M.-L.	NULL
,	NULL
and	NULL
Decker	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

158	NULL
,	NULL
165-172	NULL
Finbloom	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
and	NULL
Winestock	NULL
,	NULL
K.	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

155	NULL
,	NULL
1079-1090	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
5048-5058	NULL
David	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Larner	NULL
,	NULL
A.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
257	NULL
,	NULL
818-815	NULL
Shuai	NULL
,	NULL
K.	NULL
,	NULL
Stark	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
Kerr	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
1744-1746	NULL
Shuai	NULL
,	NULL
K.	NULL
,	NULL
Ziemieck	NULL
]	NULL
,	NULL
A.	NULL
,	NULL
Wilks	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
Harpur	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Sadowski	NULL
,	NULL
H.	NULL
B.	NULL
,	NULL
Gilman	NULL
,	NULL
M.	NULL
Z.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
866	NULL
,	NULL
580-583	NULL
Schindler	NULL
,	NULL
U.	NULL
,	NULL
Pengguang	NULL
,	NULL
W.	NULL
,	NULL
Rothe	NULL
,	NULL
M.	NULL
,	NULL
Brasseur	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
McKnight	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1995	NULL
)	NULL
Immunity	NULL
2	NULL
,	NULL
689-697	NULL
Lin	NULL
,	NULL
J.	NULL
X.	NULL
,	NULL
Migone	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
Tsang	NULL
,	NULL
M.	NULL
,	NULL
Friedmann	NULL
,	NULL
M.	NULL
,	NULL
Weatherbee	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Zhou	NULL
,	NULL
L.	NULL
,	NULL
Yamauchi	NULL
,	NULL
A.	NULL
,	NULL
Bloom	NULL
,	NULL
E.	NULL
T.	NULL
,	NULL
Mictz	NULL
,	NULL
J.	NULL
,	NULL
John	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Immunity	NULL
2	NULL
,	NULL
831-839	NULL
Wang	NULL
,	NULL
H.	NULL
Y.	NULL
,	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
and	NULL
Keegan	NULL
,	NULL
A.	NULL
D.	NULL
(	NULL
1996	NULL
)	NULL
Immunity	NULL
4	NULL
,	NULL
113-121	NULL
Yan	NULL
,	NULL
H.	NULL
,	NULL
Krishnan	NULL
,	NULL
K.	NULL
,	NULL
Greenlund	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Gupta	NULL
,	NULL
S.	NULL
,	NULL
Lim	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
Schreiber	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
Schindler	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
and	NULL
Krolewski	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

15	NULL
,	NULL
1064-1074	NULL
Fountoulakis	NULL
,	NULL
M.	NULL
,	NULL
Zulauf	NULL
,	NULL
M.	NULL
,	NULL
Lustig	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Garotta	NULL
,	NULL
G.	NULL
(	NULL
1992	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Bio-chem	NULL
.	NULL

208	NULL
,	NULL
781-787	NULL
Greenlund	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Schreiber	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
Goeddel	NULL
,	NULL
D.	NULL
V.	NULL
,	NULL
and	NULL
Pennica	NULL
,	NULL
D.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
18103-18110	NULL
Shuai	NULL
,	NULL
K.	NULL
,	NULL
Horvath	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Huang	NULL
,	NULL
L.	NULL
H.	NULL
T.	NULL
,	NULL
Qureshi	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Cowburn	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
76	NULL
,	NULL
821-828	NULL
Dighe	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Farrar	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Schreiber	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
10645-10653	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Stat3	NULL
Recruitment	NULL
by	NULL
Two	NULL
Distinct	NULL
Ligand-induced	NULL
,	NULL
Tyrosine-phosphorylated	NULL
Docking	NULL
Sites	NULL
in	NULL
the	NULL
Interleukin-10	NULL
Receptor	NULL
Intracellular	NULL
Domain	NULL
Renate	NULL
M.	NULL
Weber-Nordt	NULL
,	NULL
Joan	NULL
K.	NULL
Riley	NULL
,	NULL
Andrew	NULL
C.	NULL
Greenlund	NULL
,	NULL
Kevin	NULL
W.	NULL
Moore	NULL
,	NULL
James	NULL
E.	NULL
Darnell	NULL
and	NULL
Robert	NULL
D.	NULL
Schreiber	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1996	NULL
,	NULL
271:27954-27961.	NULL
doi	NULL
:	NULL
10.1074/jb0.271.44.27954	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/271/44/27954	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
43	NULL
references	NULL
,	NULL
28	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

